{
  "name" : "moscow.sci-hub.se_4955_8e8008f6f70936af4c6bcb69f25031c2_habibi2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery",
    "authors" : [ "Neda Habibia", "Nazila Kamalyb", "Adnan Memicc", "Hadi Shafieea" ],
    "emails" : [ "hshafiee@research.bwh.harvard.edu" ],
    "sections" : [ {
      "heading" : null,
      "text" : "ARTICLE IN PRESS+ModelNANTOD-496; No. of Pages 20 Nano Today (2016) xxx, xxx—xxx\nAvailable online at www.sciencedirect.com\nScienceDirect\nj our na l ho me pag e: www.elsev ier .com/ locate /nanotoday\nREVIEW\nSelf-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery\nNeda Habibia, Nazila Kamalyb, Adnan Memicc, Hadi Shafieea,∗\na Division of Biomedical Engineering, Division of Renal Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02139, USA b Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA c Center for Nanotechnology, King Abdulaziz University, Jeddah 21589, Saudi Arabia\nReceived 7 January 2016; received in revised form 12 February 2016; accepted 15 February 2016\nKEYWORDS Self-assembled; Peptide; Nanostructure; Drug delivery; Smart nanomaterials\nSummary Self-assembly of peptides can yield an array of well-defined nanostructures that are highly attractive nanomaterials for many biomedical applications such as drug delivery. Some of the advantages of self-assembled peptide nanostructures over other delivery platforms include their chemical diversity, biocompatibility, high loading capacity for both hydrophobic and hydrophilic drugs, and their ability to target molecular recognition sites. Furthermore, these self-assembled nanostructures could be designed with novel peptide motifs, making them stimuli-responsive and achieving triggered drug delivery at disease sites. The goal of this work is to present a comprehensive review of the most recent studies on self-assembled peptides with a focus on their ‘‘smart’’ activity for formation of targeted and responsive drug-delivery carriers. © 2016 Elsevier Ltd. All rights reserved.\nt Introduction\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nMolecular self-assembly is the spontaneous formation of ordered structures. These processes occur under\n∗ Corresponding author. E-mail address: hshafiee@research.bwh.harvard.edu\n(H. Shafiee).\nq H i t t m [\nt\nhttp://dx.doi.org/10.1016/j.nantod.2016.02.004 1748-0132/© 2016 Elsevier Ltd. All rights reserved.\nhermodynamic and kinetic conditions that are a conseuence of specific and local molecular interactions [1]. ydrogen bonding, hydrophobic interactions, electrostatic nteractions, and van der Waals forces combine to mainain molecules at a stable low-energy state. Self-association o form hierarchical structures at both nano and/or\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nicroscales occurs in order to achieve minimal energy state 2].\nSelf-assembly occurs spontaneously in nature during proein folding, DNA double-helix formation, and the formation\nIN+ModelN 2\no r a s t t i p f\nV\nt e T u p g t t a i p a a a p t f k c\nS\nS p t ( t s\ni t f\nP\nF p H h t\nb w o a h i a a\no t c a o S c t h a\nb c a b s s o f [\nO i p V p h i i ‘\nARTICLEANTOD-496; No. of Pages 20\nf cell membranes [3]. Self-assembling nanostructures fabicated from natural biomolecular building blocks such s amino acids are highly preferable to their synthetic elf-assembled monolayer (SAMs) alternatives [4] due to heir biocompatibility and ease of ‘‘bottom-up’’ fabricaion [5]. Although several self-assembly platforms have been ntroduced for biomedical applications, self-assembling eptides remain the most attractive soft biomaterial option or several reasons:\nI. Peptides are easily synthesized using solid-phase methods, which allows for sequence-specific modifications at the molecular level [6].\nII. Additional peptide functionalization can easily be performed by introducing compounds such as antibodies, enzymes, magnetic particles, or fluorescent compounds to the peptide structure [7].\nIII. Custom supramolecular structures can be designed through engineering of self-assembled peptide building blocks [6]. IV. Naturally occurring self-assembly motifs present in proteins such as -helices, -sheets, and coiled-coils can be used to drive the self-assembly process [8].\nV. Peptides are the most attractive biomaterials for regenerative scaffolds, since the main ‘‘signaling language’’ in the extracellular matrix (ECM) is mediated via peptide epitopes [9]. I. Self-assembly is important in cell-penetrating peptide (CPP) mechanisms, which play a major role in introducing drugs inside cell membranes and translocating genes inside a nucleus [10].\nThough there have been several reviews on peptides and heir self-assembling properties, most are focused on tissue ngineering rather than drug-delivery applications [11—13]. herefore, there is a lack of comprehensive review on the se of self-assembled peptides as ‘‘smart’’ drug-delivery latforms that are capable of specific tissue or cellular tareting, and release of therapeutic components in response o environmental cues. The focus of this review is on factors hat govern self-assembled peptide (SAP) targeting activity nd controlled-release properties. We aim to provide insight nto how SAPs can be engineered into smart drug-delivery latforms that exhibit enhanced biological functions, such s intracellular and targeting uptake, controlled release, nd reversible enzymatic hydrogel formation. Finally, we lso cover a broad range of self-assembled peptides and eptide derivatives. We believe that this review highlights he importance of self-assembled peptide nanostructures or nanomedicine applications and can facilitate further nowledge and understanding of these nanosystems towards linical translation of such therapeutic materials.\nelf-assembled peptides\nelf-assembled peptides were categorized into peptides and eptide derivatives according to their building blocks. In\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nhe section on peptides, naturally occurring peptide motifs -helical, -sheets, -hairpins, etc.) are discussed and in he section on peptide derivatives, self-assembled peptides uch as peptides amphiphiles (PAs) with alkyl chains are\nh p r s\nPRESS N. Habibi et al.\nntroduced. Relevant examples are presented to highlight he importance of these structures as basic building blocks or targeted drug-delivery carriers.\neptides\n-Helical peptide/coiled coil or decades it has been known that physical and biological roperties can promote the formation of helical structures. owever, with the advent of material design, only recently ave key molecules been discovered in order to incorporate hese helical structures into biomaterials.\nThe -helical structure results from hydrogen bonding etween backbone amides that form right-handed -helices ith a periodicity of 3.6 residues per turn. Interaction with ther helices are possible through the side chains of the mino acids involved, as they protrude outwards from the elix. However, it is challenging to produce these structures n practice, in part because longer lengths (20—30 amino cid) are usually required to establish stable -helical interctions.\nCoiled-coil structures are formed through the assembly f -helices into higher ordered structures. These architecures form due to the repeated pattern of hydrophobic and harged amino acid residues. In 2009 Smith et al. reported\nself-assembled hydrogel [14]. This novel design consisted f two complementary leucine-zipper peptides (SAF-p1 and AF-p2), which co-assembled into a sticky-ended dimer with omplementary overhanging ends. Multiple weak interacions between the fibers prompted the formation of the ydrogel, which was shown to support PC12 cell adhesion nd proliferation into neurons [14].\n-Sheet -Sheets are the most common natural motifs that can e used in driving the self-assembly of peptides. -Sheets onsist of sequences that possess alternating hydrophobic nd hydrophilic amino acids, providing the peptide backone an amphiphilic property that directs formation of -sheets. Fishwick et al. proposed that the P11-II peptide equence QQRFQWQFEQQ and its derivatives form twisted - heet tapes, naturally reinforced by the amphiphilic nature f the sequence. These -sheet tapes are triggered to orm hydrogels by screening the charges between fibers 15].\n-Hairpin rientation of two -sheets in anti-parallel directions results n formation of -hairpins in proteins. Shneider et al. [16] roposed a -hairpin structure design with the sequence KVKVKVKVDPPTKVKVKV, where DP is an enantiomer of roline. This peptide possesses an alternating hydrophilicydrophobic motif and intermittent tetrapeptide (-VDPPT-) ntended to form a type II′ turn structure. This design allows ntra-molecular folding and -sheet formation, yielding a ‘hairpin’’ structure that can subsequently associate into\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nigher-order fibers and self-supporting hydrogels when the H is raised. These structural designs were used to form esponsive hydrogels, linking pH intra-molecular folding to elf-assembly.\nARTICLE IN PRESS+ModelNANTOD-496; No. of Pages 20 Self-assembled peptide-based nanostructures 3\no fib ix [12\nD D a o t S n a i n a e\nf I s p t T h b T b t FF structures together. The interactions between the sidechain aromatic rings create well-ordered tubular structures of significant length (100 m) [5,24].\nFigure 1 Design of a collagen peptide that self-assembles int between Lys and Asp at the ‘sticky end’ of a collagen triple hel\nThe -hairpin MAX1 presented by Schneider et al. exhibited inherent antibacterial activity against both Grampositive and -negative bacteria, likely due to the material disruption of the bacterial cell membrane [17]. Analogously, most cationic peptides that form -helices or -sheet-like structures could be inserted into and thus disintegrate negatively charged bacterial cell membranes [18].\nTriple helical peptides (collagen mimetic peptides) Collagen is the most abundant protein in the human ECM, interacting with cell-surface integrins for adhesion [6]. Collagen isolated from animals has been extensively used for engineering numerous tissue-mimicking scaffolds in vitro. However, due to the complex characteristics of collagen fabrication, creating hybrid scaffolds that combine collagen with other biomaterials is difficult. Other challenges including immunogenicity, poor mechanical properties, and the lack of tissue-specific adhesion ultimately limit the utilization of purified collagen for making tissue-engineered scaffolds. To recapitulate native tissue architecture and chemical composition, studies have been carried out using a ‘‘bottom-up’’ approach to mimic the structure and functionality of collagen proteins with shorter peptide sequences [6].\nEarlier studies of collagen mimetic peptides (CMPs) based on the sequence -(Pro-Hyp-Gly)x- or -(Pro-Pro-Gly)x(where Hyp = hydroxyproline) have used models exploring the structure and stability of collagen triple helices [19]. A collagen fiber is constructed when three peptide chains come together to form a triple helix. Building new biomaterials is possible once the subunits assemble into larger fibers that form crosslinks, which generate 3D scaffolds. To construct 3D scaffolds, CMPs have been incorporated in hydrogels such as photo-polymerizable poly (ethylene oxide) diacrylate PEODA or PA molecules [20]. Hartgerink et al. developed hydrogels purely based on peptide interactions. They initially developed these structures using trimers with sticky ends capable of directing the assembly of larger fibers into scaffolds (Fig. 1) [21]. These gels had mechanical properties similar to those of native collagen gels, and could even be degraded by collagenase enzymes. These mimetic peptides have tremendous applications in drug-delivery sys-\nPlease cite this article in press as: N. Habibi, et al., Nano Today\ntems, since they can be combined with therapeutic drugs or cells and then injected into tissues, where they can selfassemble into stable gels capable of delivering therapeutic components.\nF f p\nrous hydrogels by the aim of electrostatic interaction initiated ] Printed with permission from ACS.\ni-phenylalanine (FF) i-phenylalanine (FF), with the structure L-Phe-L-Phe, is peptide building block associated with the pathogenesis f Alzheimer’s disease. It was identified from Alzheimer’s -amyloid polypeptide studies, where it was proposed as he core recognition motif able to guide self-assembly [22]. ince Reches et al. reported that di-phenylalanine produces anotubes [23], many studies have been carried out to form\nvariety of functional nanostructures from FF-based buildng blocks such as nanotubes, spherical vesicles, nanofibrils, anowires, and ordered molecular chains (Fig. 2). The pplication of FFs includes bioimaging, biosensors, guest ncapsulation, nanofabrication as well as drug delivery.\nFF is an aromatic dipeptide that displays interesting eatures as a building block for tubular nanostructures. n its self-assembly, cyclic hexamers are formed with ix FF units (Fig. 3). Subsequently, stacking of hexamers roduces narrow channels, which leads to the formaion of self-assembled sheets due to hexagonal packing. he coiling of the sheets produces nanoscale tubes with ydrophobic external walls. Finally, these nanotubes can e self-assembled on even larger scales, forming bundles. he self-assembly processes are illustrated in Fig. 3. The ackbone hydrogen bonds and bond interactions from he aromatic peptide side-chains hold the self-assembled\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nigure 2 Schematic representation of various nanostructures ormed by self-assembly of FF-based building blocks and their otential applications [5] Printed with permission from RCS.\nARTICLE IN PRESS+ModelNANTOD-496; No. of Pages 20 4 N. Habibi et al.\nFigure 3 Schematic representation of the multiscale self-assembly of the FF-microtubes and their conjugation to RhB. FF hexamers self-associate to form narrow channel arrays, which give rise to nanotubes. Subsequently, these nanotubes cluster into larger m drop\np\nc b b t c n t T g o s h d p t d\nt a a d h c e R d d i r c p\nc w R a m r a t a g n T e t T c a a d t\nP\nP T p i\nicrotubes. The inner surfaces of the nanotubes exhibit both hy\nolar species [24] Printed with permission from ACS.\nFF nanotubes have been transformed into spherical vesile structures by diluting the solution of FF in pH 7. It should e emphasized that different morphologies can be created y simple modification of the solution’s parameters, such as he solvent used and its concentration level. In fact, conentration of FF plays a critical role in defining the final anostructure morphology. The transition from FF nanotubes o vesicles is reversible and dependent on FF concentration. his is attributed to the sufficient free energy association ained by intermolecular interaction at high concentrations f FF (100 mg/ml), while decreased concentrations disasemble the organized arrangement (Fig. 4) [25]. Yan et al. as described, in more detail, the various nanostructures erived from FF, their self-assembly mechanisms, and their otential applications [5]. Despite the tremendous advanages of FFs as basic building blocks, research on FFs as rug-delivery systems has been scarce.\nIn 2013, Silva et al. reported utilizing FF peptide nanoubes for loading rhodamine. This platform was intended s a model system conjugating a hydrophilic drug to selfssembled peptide arrays [24]. The aim was to obtain ata related to the location of the drug based on its ydrophilic characteristics on peptide arrays. There was lear formation of microtubular needles with average diamter of 2.2 m (Fig. 5a). The homogeneous distribution of hB fluorescence across the needles suggests uniformity of rug conjugation with the peptide structures (Fig. 5a). For etailed analysis, colocalization was performed by label-\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nng the nanotubes with both ZcPc (a highly hydrophobic eagent colored green) and rhodamine (a hydrophilic drug olored red). Typical drug distribution images are dislayed in Fig. 5b and c. The surface of the nanotubes was\nP a t r\nhobic and hydrophilic groups, with the latter being able to trap\novered with the non-polar dye (green) and was co-located ith RhB at various points. These results suggest that the hB was conjugated not only to the external surfaces of the rrays but also on the inside of the structures. Atomic force icroscopy (AFM) results showed FF microtubes (FFMTs) carying cargo in either of two conformations: either as small ggregates located on the surface or homogeneously disributed within the structure (Fig. 5e and f). These results re attributed to the arrangement of polar and non-polar roups in the organization of nanotube arrays. The exteral and internal walls of the FFMTs are highly hydrophobic. he walls are composed of aromatic rings that make up ach of the two FF side chains. Alternatively, in the pepide matrix, additional sites could host hydrophilic moieties. herefore, both hydrophilic and hydrophobic compounds ould be hosted in these FF nanotubes, giving them an dvantage over other platforms [24]. However, FF peptides re still better overall carriers for hydrophobic components ue to their large number of hydrophobic aromatic funcional groups [24].\neptide derivatives\nAs with alkyl tail he most well-known PAs are molecules with hydrophilic eptide sequences linked to a hydrophobic tail. Accordng to a definition proposed by Kunitake in 1992, a typical\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nA consists of a hydrophobic tail, a linker, a spacer, and hydrophilic head [26]. These kinds of amphiphilic pepide molecules have four regions: (1) amino acids (charged esidue) or hydrophilic peptides; linked to (2) hydrophobic\nARTICLE IN PRESS+ModelNANTOD-496; No. of Pages 20 Self-assembled peptide-based nanostructures 5\nARTICLE IN PRESS+ModelNANTOD-496; No. of Pages 20 6 N. Habibi et al.\nFigure 6 Chemical structure and space filling model of PA molecule, and Illustration of a self-assembled PA nanofiber (red spheres representing water molecules). The four regions represent the unbranched alkyl (usually palmitic acid) tail (region I), (a) -sheet amino acid sequence to promote formation of fibril structures through H-bonding (region II), charged amino acids to induce solubility and fiber crosslinking (region III) and a peptide signaling epitope for biological response (region IV) [8,131] Printed with permission f\na l\ns f s p p o s [ u w s g b t\ni d j f a f\nt e a o n H w a c f h w m a a p T h\ni fi m\nc s t ( a p ( a a o t e s t T p c s\nt T a a c t i p m t t i t d\np\nrom ELSEVIER.\nlkyl chains or lipid tail; (3) -sheet sequence; and (4) bioogical epitope for desired function (Fig. 6) [6].\nOnce a PA with an alkyl chain is exposed to an aqueous olution, the hydrophobic tail of the peptide shields itself rom water to induce and/or stabilize a three-dimensional tructure of a peptide head group, driving the self-assembly rocess to form protein-like molecular architectures. This rocess is similar to spontaneous protein folding. As a result f this self-assembly process, various types of structures uch as nanofibers [8], micelles and vesicles [27], nanotapes 28], nanotubes, and ribbons are constructed to reduce the nfavorable interactions of their hydrophobic components ith their surroundings. For example, introducing -sheet equences into the structure of PAs often results in the eneration of cylindrical nanofibers with diameters ranging etween 6 and 10 nm and lengths of up to several micromeers.\nOne of the first PAs was described by Bertranda et al. n 1995 [29]. The design consisted of a peptide sequence erived from collagen (a1(IV) 1263—1277 (called IV-H1), conugated onto C12, C14, and C16 mono- and dialkyl tails to orm amphiphilic collagen-like peptides. These structures re usually generated as a monolayer at the air—water interace.\nThe morphology, functionality, and surface characterisics of PAs can be altered simply by changing the structural lements of the amphiphilic molecules. Stupp’s group played\nsignificant role in pioneering various PA molecules based n their understanding of the self-assembly mechanism of anofibers for tissue-regeneration applications [30]. In 2001 artgerink et al. developed PAs that allowed mineralization ith hydroxyapatite, which mimics the bone ECM to crete bone-interfacing biomaterials [21]. The PA molecules onsist of five regions: (1) alkyl tail; (2) cysteine residue or polymerization; (3) glycine residue for the hydrophilic ead group; (4) phosphorylated serine residues to interact ith the calcium of hydroxyapatite; and (5) a cell-adhesion otif consisting of Arg-Gly-Asp RGD. The design of the PA llows formation of nanofibers with reversible cross-linked\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nctivity. In this case, the phosphorylated residue of the PA rovided the possibility of interaction with hydroxyapatite. herefore, the fibers were able to guide mineralization of ydroxyapatite. This alignment was shown to be similar to\ni i a f\nnteractions between hydroxyapatite crystals and collagen brils in natural bone, demonstrating the potential of PA olecules for mimicking the architecture of ECM fibers [21]. In 2010 Zhang et al. discovered another remarkable appliation of PA, which allows cell encapsulation for applications uch as blood-vessel engineering [31]. The PA molecules in heir study were made from a C16 alkyl tail and a V3A3E3 CO2H) peptide sequence and were able to self-assemble nd form a gel. When sheared gently (e.g., as by the force of ipetting), these PA solutions formed aligned monodomains Fig. 7a); and when divalent cations like calcium were dded, the fibers formed string-like ‘‘noodle’’ gels with fiber lignment over macroscopic distances (Fig. 7c). The strings f aligned nanofiber gels were used to direct the orientaion and alignment of mesenchymal stem cells (hMSCs) and ncapsulate them in 3D culture (Fig. 7b). The process of tring formation did not affect cell viability, and within 12 h he cells started to elongate in direction of the string axis. hus, these PAs could eventually support advanced theraies that require guided cell growth, migration, or spatial ell interconnections in numerous tissues that include the pinal cord, heart, and brain.\nThe utility of PA for drug delivery has also been invesigated by Fernandez-Carneado et al. from Giralt’s group. hey were able to combine a proline-rich sequence (i.e.,\nfamily of cell-penetrating peptides or CPPs) with fatty cid moieties for internalization in HeLa cells [32]. Flow ytometry and confocal laser scanning microscopy indicated hat including fatty acids into the CPP structure significantly mproved internalization. Studying the interaction of these eptides with model dioleoylphosphatidylcholine (DOPC) embranes demonstrated that the identity and length of he fatty acyl moieties are crucial for cell membrane peneration. Therefore, using C6 fatty acids did not lead to any mprovement in internalization. This highlights the imporance of the structural design of PAs for their targeted drug elivery [32].\nSardan et al. designed a cell-penetrating arginine-rich eptide with a lauryl structure (C12)—–PPPPRRRR-NH2,\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nntegrated non-covalently into liposomal structures to mprove bilayer penetration of MCF7 cancer cells. The mphipathic properties of the peptide eliminated the need or crosslinking methods used for integration into liposome\nARTICLE IN PRESS+ModelNANTOD-496; No. of Pages 20 Self-assembled peptide-based nanostructures 7\nFigure 7 (a) Alignment of encapsulated human mesenchymal stem cells (hMSCs) along the string axis; (b) Calcein-labeled aligned cells cultured in string PA; (c) solution colored with trypan blue injected into phosphate buffered saline after heat treatment [31]\na i c t r u p\nS I l i a o m o s g a p e\nt l u d i t e a s c s s i a o\nt hydrogels. These small molecule-based hydrogels can be\nPrinted with permission from NPG.\nformulations [33]. The effectiveness of peptide integrated liposomal system as drug delivery platforms was investigated by using the anticancer drugs doxorubicin-HCl and paclitaxel. Compared to free drugs, peptide-functionalized liposomes enhanced cell uptake.\nIn 2012 Matson et al. designed four PAs with hydrazone groups linked to ketone-containing model drugs such as prodan, via hydrazine linkages [34]. The peptide-based C16-V2A2E2 sequence self-assembled into hydrogels. For example, by controlling hydrazone hydrolysis, sustained drug-release profiles could be attained in an aqueous medium at physiological pH. However, based on their results it was concluded that the packing density of the assembled nanofibers of PAs was the most significant factor controlling drug-release kinetics. Furthermore, as the hydrophobic PA core and -sheet activity and order decreased, the release rates increased.\nIn 2008 Cui et al. demonstrated an interesting morphologic transformation of PAs consisting of a 2-nitrobenzyl group, a palmitoyl tail, and an oligopeptide GV3A3E3. The N-terminal amide of the glycine residue was covalently attached to the 2-nitrobenzyl group and was susceptible to cleavage by 350 nm irradiation. Interestingly, the quadruple helical structure was transformed to a typical cylindrical nanofiber upon irradiation at 350 nm, indicating its potential use as a responsive system for a broad range of targeted delivery medicine [13].\nPAs with only amino-acids (self-complementarity) PAs composed solely of amino acids contain both hydrophilic and hydrophobic domains organized in an amphiphatic sequence. In PAs with an alkyl chain, the self-assembly process is governed by helices, while ionic interactions play a secondary role. In these types of peptides, however, electrostatic interaction plays a major role. The structure of these peptides is based on the self-complementary nature of ionic bonds within alternative repeating units of negatively charged amino acids (i.e. Glu and Asp) and positively charged amino acids (i.e., Lys and Arg) [35] Once exposed to aqueous solutions, the hydrophobic part shields\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nitself from water, driving the process of self-assembly. This approach was first demonstrated by Zhang et al. in 1993 with the sequence (AEAEAKAK)2 derived from the yeast protein zuotin [36]. The alternating hydrophobic region and charged\nu s fi c\nmino acid region forms a -sheet structure together with onic bonds between positively charged K and negatively harged A side chains. Later, a new structure was introduced ermed (RARADADA)2 or RADA16, which replaced the E esidues with D and the K residues with R and was widely sed to create hydrogel scaffolds for controlled release of roteins and small molecules.\nmall-molecule peptides with aromatic tail n 2009, Xu proposed formation of supramolecular hydrogeators from small molecules. Through several non-covalent nteractions that include — stacking, hydrophobic interctions, hydrogen bonding and van der Waals forces, small rganic molecules can form gels. These are referred to as olecular hydrogelators since they can interact with each ther to produce gels [37]. Recently, several groups have tarted to develop ‘‘self-delivery’’ systems based on hydroelator principles, where the goal is to use therapeutic gents [31,38] to form gels with superior pharmacokinetic rofiles. Currently, one of these hydrogelator systems was ven approved for clinical use by the FDA [39].\nIn addition to commercial drug formulations, several herapeutic agents that include drug candidates such as anreotide, Ganirelix, Biotin, and F-moc L-lysin have been sed to form hydrogelators [37]. Some of these candiates can by themselves undergo spontaneous self-assembly nto supramolecular hydrogels, while others require addiional functionalization or structural modifications. Using nzymes such as -lactamases and phosphatase/kinases s models, Yang et al. illustrated the formation of upramolecular hydrogels. The design and tuning of enzymeatalyzed hydrogelators could offer novel strategies for creening enzyme inhibitors and developing drug-delivery ystems. Yang et al. introduced the concept of producng antibacterial effects from within the cell itself. They ccomplished this through enzyme-regulated self-assembly f small molecules inside cells [40].\nSimilarly, using Fmoc-FF and Fmoc-RGD, co-assembly of hese aromatic peptide amphiphiles can generate bioactive\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nsed to mimic ECM. Ultimately, when combined with cells uch as dermal fibroblasts, these hydrogels can form dense brous networks through the robust secretion of ECM from ells even within these simple Fmoc-FF/RGD scaffolds [41].\nIN+ModelN 8\nP\nF s s t N i b i t p Q s s s O h c s p s a t i\nB p\nC s\nB o t s d a p\na t m s m t i p [\nt p v s m a t\np a t\nc h c\nt f p t r r d o\no i s a s o\nS e T n c s b c m m p t e\nh s t o p s t L i i o\nR i s o r l t w d a a\nARTICLEANTOD-496; No. of Pages 20\neptide synthesis routes\nor more than a century, peptide synthesis has had a ignificant impact in several fields including pure organic ynthesis and protein chemistry. The formation of pepides usually occurs via repetitive amidation reactions. The -terminal amino group and the carboxylic group of an ncoming amino acid are coupled to produce the peptide ond. Bruce Merrifield was one of the pioneers of utilizing nsoluble resins as support during the synthesis of pepides that could then be cleaved off at the end of the rocess to isolate the final peptide in solution [42,43]. uickly these strategies were adopted in solid-phase peptide ynthesis. However, remaining challenges include matrix welling, limited selection of linker groups, and the necesity of using protecting groups for some amino acids. ver the last 15 years, advances in the peptide industry ave lowered the cost of raw materials and improved the hromatographic methods used for peptide purification. It hould be mentioned that the number of animal-derived eptides on the market is decreasing implying that the olid phase methods are becoming more economics. In ddition, the use of enzymatic procedures (reversed proeolysis) to synthesize specific sequences is gaining renewed nterest [44].\niomedical applications of self-assembling eptide-based nanostructures\nontrolled and triggered-release from timuli-responsive hydrogels\nioactive peptide molecules capable of self-assembly into rdered supramolecular structures are ideal building blocks o form hydrogels, scaffolds, and nanofiber gels for use in tisue engineering, regenerative medicine [45], and injectable rug formulations [46,47]. The interest in utilizing selfssembled systems stems from their advantages over other olymers in forming hydrogels.\nPeptide-based hydrogels can be fully biocompatible nd capable of incorporating functional molecules into heir scaffolds [48]. Manipulating these structures at the olecular scale offers the remarkable capability of tuning ome features such as chemical material, viscoelastic and echanical properties. Incorporating bio-functionality into he material ligand and metal recognition, biodegradabilty and biocompatibility is now possible through employing eptide-based molecular building blocks for self-assembly 49].\nThis technology also allows specific sequence modificaions at the molecular level that eventually affects the bulk roperties of the hydrogel. Thus small amino-acid sequence ariations can be used to tune material properties through olid-phase methodology. Thoughtful design of individual olecules used in preparation of biological scaffolds via selfssembly makes it possible to determine the properties of he larger material [47].\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nPreparation of self-assembled hydrogels from short eptides relies completely on self-assembly, which takes dvantage of the intra-molecular folding of specific pepides. This process eliminates the need for the toxic\nC s k p\nPRESS N. Habibi et al.\nross-linker reagents commonly necessary for building ydrogels from high-molecular-weight polymers thorough hemical crosslinking techniques.\nImportantly, these types of peptides are designed such hat release properties are responsive to intramolecular olding events. Advanced drug carriers need to be biocomatible, robust, and capable of slow release at specific times hrough the entire path of delivery, and must have triggered elease based on the requirements of the therapy. In this egard, increased therapeutic efficacy could be achieved by esigning peptides that are stimuli responsive and capable f controlled release [50].\nSelf-assembling peptide hydrogels are an important class f hydrogels. They are potentially good choices for preparng a strong drug delivery system able to respond to external timuli under variable physiological conditions of temperture and pH [50]. Discussed here are the capabilities of elf-assembling peptide molecule designs amenable to tailring for the specific needs of therapy.\ntimuli-responsive hydrogels with physically ncapsulated drugs he KLD12 peptide (Ac-KLDLKLDLKLDL) is known for its alterating hydrophobic and ionic hydrophilic amino acids, which an form established -sheet hydrogel structures in aqueous olutions [51]. Based on this, Law et al. designed a peptideased hydrogel KLD12 that is sensitive to protease and ontained a protease-cleavable region in the self-assembling otif [52]. The peptide hydrogel, when exposed to enzyatic treatment, released its drug via a model therapeutic ro-apoptotic peptide. Further use of self-assembled pepide sequences could allow release of therapeutics upon xplicit interaction with proteases associated with disease.\nYishay-Safranchik et al. examined the design of a peptide ydrogel formed from self-assembling KLD motifs with two eparate -sheets linked with three or four glycine spacers o prolong the release of doxorubicin (DOX) and Smac (secnd mitochondria-derived activator of caspases)-derived ro-apoptotic peptide (SDPP) [47]. The two separate - heets act as a cross-linker for the hydrogel, which prolongs he release rate, while a penetrating sequence (harboring ys, KRRMKWKKK (FITC)) was added to the C terminus to ncrease uptake of hydrogel by cells. The hydrogel could be njected in situ, advancing both the safety and effectiveness f cancer chemotherapy.\nA novel hydrogel scaffold formed from self-assembling ADA16 has been reported by Zhang et al. [35]. RADA16\ns characterized by a stable -sheet structure consisting of ystematic repeating units of positively charged (arginine r lysine) and negatively charged (glutamate or aspartate) esidues disjointed by hydrophobic residues (alanine or eucine) (Fig. 8a). The scaffold is formed once it is exposed o physiological solutions and consists of more than 99% ater (Fig. 8d.). The scaffold remains fully biocompatible ue to the fact that no chemical or physical treatments re required. Controlled release of small molecules such s bromophenol blue, phenol red, 8-hydroxypyrene, and\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\noomassie Brilliant Blue G-250 (CBBG) from RADA hydrogel caffolds was studied using diffusion models. The release inetics correlated to the chemical structure of the comound and the concentration of gel provide an alternative\nARTICLE IN PRESS+ModelNANTOD-496; No. of Pages 20 Self-assembled peptide-based nanostructures 9\nFigure 8 (a) Schematic illustration of the RADA16 molecule composed of negative (Asp) and positive (Arg) residues driving the assembly of the peptide by means of electrostatic interactions into (b) and (c) fibers and (d) macroscopic hydrogels in buffer [50]\nfi w t t\np d s w s i p a a a T r t\na d a t t\nS d I\nPrinted with permission from ELSEVIER.\nmeans of controlling release kinetics. The results indicated that release profiles can be tailored by controlling nanofiberdiffusing molecular-level interactions [50].\nA variety of proteins, such as lysozymes, trypsin inhibitors, BSA, and IgG were also encapsulated within the Ac-(RADA)4-CONH2 peptide hydrogel and released slowly [53]. The combination of the peptide solution and therapeutic-based proteins could be used for local drug release in tissue.\nElastin is a highly elastic protein in connective tissues that helps the tissues to resume its shape after extention or contraction. Recombinant techniques allow one to create protein-based materials that exhibit some feature found in natural proteins together with other properties of technological/medical interest. One of the most interesting protein-based materials is the family of elastin-like recombinamers (ELRs), which can form a variety of structures such as nanoparticles, nanofibers, films, and hydrogels.\nAlicia et al. designed a silk-elastin-based injectable multiblock corecombinamer that spontaneously forms a physically stable nanofibrillar hydrogel under physiological conditions. The idea was to create a system as the basis for developing injectable fibrillar biomaterial platforms toward a fully functional, biomimetic, artificial ECM, and cell niches [54].\nMachado et al. investigated the use of ELRs for the transplantation of autologous retinal pigment epithelial (RPE) cells for treatment of age-related macular degeneration,\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nsince they were shown to maintain the functional features of (RPE) cells [55].\nInspired by the cells’ structure, Torre et al. [56] presented compartmentalized capsules responsive to magnetic\nn o p p\neld and temperature. The microcapsules were coated ith a temperature-responsive chitosan/ELR nanostrucured shell. These engineered systems can be applied for ransportation of bioactive agents and cells.\nThe effects of pH on intramolecular folding of -hairpin eptide self-assembled hydrogels were studied by Schneier et al. [49]. Infrared spectroscopy and circular dichroism howed that at low pH, individual peptides in the hydrogel ere unstructured, resulting in a low viscosity and aqueous olution. Thus, varying the intramolecular folding of small ndividual peptides on the nanoscale can alter macroscopic roperties [49]. -hairpin self-assembled hydrogels were lso used to encapsulate curcumin; an anti-inflammatory ntioxidant and anti-tumorigenic polyphenol derived from\nplant, whose therapeutic use is limited by poor solubility. he peptide hydrogel has been proven to be an effective carier for the localized, consistent delivery of curcumin over ime [57].\nOne challenge to the controlled-release use of selfssembled nanofibers is their extreme resistance to egradation by protease. Collier et al. designed selfssembling depsipeptides that contain ester bonds within he peptide backbone; these degraded in a period of days o weeks by ester hydrolysis [58].\ntimuli-responsive hydrogels with chemically conjugated rugs\nn the past decade, supramolecular hydrogels, with\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\networks of nanofibers formed through the self-assembly f small molecules (i.e., hydrogelators), have proven to be romising biomaterials. Peptide-based hydrogelators have roven their effectiveness due to their ability to produce a\nIN+ModelN 1\nl o s t a\nX o w\na a c p a a\nn r o u n b i b\nr c D a p a a t h c u c o t a t t g o\ng a w i [\nE\nO b b r A b a\no ( m S t s v a p S i f t a a r p c\nT D b b m i p n p g\ns d a t p e r t f b a t c y t specifically recognizes and binds to cells expressing 5 1. Functionalizing stealth PEG-liposomes decorated with PR b peptide-amphiphile [69] were found to function better than\nARTICLEANTOD-496; No. of Pages 20 0\narge set of various functional molecules from a small array f residues. The combination of enzymatic reactions with elf-assembly of small molecules offers an effective method o form nanofiber networks, which results in hydrogels under\nvariety of conditions. Studies have been undertaken by several groups including\nu’s and Yang’s, who have been investigating development f supramolecular hydrogels from self-assembly of peptides ith chemically conjugated drugs [40,59—61].\nLi et al. conjugated Taxol with a self-assembly motif and functional group cleavable by an enzyme. A precursor has lso been designed for developing a Taxol hydrogel without ompromising the activity of Taxol [59]. This approach holds romise as a general method to generate nanofibers of therpeutic molecules with a dual role: delivery carrier as well s drug.\nIn another study, tripeptide derivatives containing a aphthyl group, two phenylalanines, and one modified lysine esidue were conjugated to an olsalazine moiety (substrate f azo reductase), which self-assembled into a hydrogel nder mildly acidic conditions. The reduction of olsalazine ot only led to a transition from gel to solid phase, ut also released 5-aminosalicylic acid, which is an antinflammatory agent. This approach will eventually yield new iomaterials for site-specific drug delivery.\nOne of the first molecular hydrogelator systems was eported by Mao et al. in 2011; it was made of two antiancer drugs that complement each other. In this study ex-FFFK(Taxol/HCPT)E-ss-EE was designed and synthesized s a precursor of molecular hydrogelators. The princile of this novel design included Dexamethasone regularly pplied to drive self-assembly (also an anti-inflammatory nd immunosuppressant used after chemotherapy); dipepide and tripeptide of phenylalanine (F) to form molecular ydrogelators; and finally the disulfide bond, acting as a leavable linker connecting the hydrophilic parts and moleclar hydrogelators. This structures could be applied in the avity after surgical tumor removal for the long-term release f anti-cancer drugs [60]. This injectable self-delivery sysem contains a high weight percentage of anti-cancer drugs nd can prolong their release [62]. Further, Wang et al. found hat even the conjugates of Taxol with amino acids conaining hydrophilic side chains such as serine, arginine, and lutamic acid were also efficient candidates for formation f molecular hydrogelators [61].\nUltra-short peptides with the ability to form hydroels were functionalized with oxaliplatin (a platinum-based nticancer therapeutic). The oxaliplatin-peptide conjugate as tested for localized breast cancer therapy, and the njectable gel showed significant tumor growth inhibition 63].\nnhanced cellular uptake with targeting activity\nne of the most desirable properties of a drug carrier is to ind specifically with the target site [9], whether cell memranes [64] or molecules of interest. To this regard, peptides\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nepresent the most important biological recognition motifs. s an example, NTFR and RGD PAs have been widely used y researchers to bind fractalkine and a5 1 integrins. Selfssembled peptides are used to enhance the functionality\nF C\nw\nPRESS N. Habibi et al.\nf common motifs and integrins. Cell-penetrating peptides CPP) play an important role in introducing drugs inside cell embranes and translocation of genes inside the nucleus. elf-assembly is key to CPP penetration mechanisms. Furhermore, the self-assembly process can produce various tructures suitable for specific delivery and loading of a ast array of drugs. In this regard, PAs (which contain an lkyl chain) mimic the capabilities of lipid systems, thus roviding improved drug-delivery through cell membranes. elf-assembled peptides have also been used to functionalze conventional drug delivery carriers, such as liposomes, or enhanced cellular uptake and targeting [65]. In addiion, folate-targeting functions have been investigated for nticancer drug delivery [66]. Functional groups of selfssembled structures act as a template for the alignment of ecognition molecules [67]. Self-assembled peptide motifs lay a critical role in increasing targeting activities of drug arriers.\nargeting function to improve uptake rug delivery carriers designed with peptide motifs have een extensively studied for targeted delivery. PAs have een designed to enhance the targeting activities of comon recognition motifs. For example, researchers have nitially applied RGD (the primary recognition site for 5 1) eptide-based techniques to target the integrin 5 1 (sigificantly up-regulated in tumor vasculature). However, this rocess has limitations, since RGD recognizes several interins, making specific targeting difficult.\nGarg et al. designed a novel peptide-amphiphile equence namely PR b that closely mimics the cell adhesion omain of fibronectin [65]. The design structures included\nC16 dialkyl ester tail, a glutamic acid (Glu) tail connecor, a — (CH2)2 — tail spacer, and a peptide headgroup. The eptide headgroup contained a spacer KSS, PHSRN (the synrgy site for 5 1), a linker (SG)5, and RGDSP (the primary ecognition site for 5 1) (Fig. 9.). The KSS spacer was used o keep the bioactive region further away from the interace so the availability of the peptide could enhance the inding affinities to the targets [9,68]. The PR B peptidemphiphiles were incorporated on stealth liposomes in order o target integrin 5 1, which is expressed in colon cancer ells. Functionalized liposomes were covered with polyethlene glycol (PEG). The role of PEG is to allow the liposomes o circulate in the blood, while the modified PR b peptide\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nigure 9 Structure of PR b peptide-amphiphile containing 16 dialkyl ester tail, a glutamic acid (Glu) tail connector, a (CH2)2 tail spacer, and the peptide headgroup [65] Printed ith permission from ELSEVIER and PUBMED.\nIN+Model\nr t t s e s t t\ns a W H t a d\n[ m a s s\ns i\nARTICLENANTOD-496; No. of Pages 20 Self-assembled peptide-based nanostructures\nRGD targeting, providing better binding and greater uptake of liposomes by colon cancer cells. The ability to design a peptide by sequence-specific modifications at the molecular level allows control of the activities of common motifs for desired applications [9].\nMembrane penetration function to improve uptake Cell-penetrating amphiphilic peptides such as HIV-Tat based peptides, oligoarginines, and chimeric cell-penetrating peptides have also been applied alone or in combination with other self-assembled peptides for the delivery of therapeutic cargos to their targets [70].\nCPPs have been used as drug delivery vehicles, because they are able to translocate the cell membrane [71]. CPPs, which are cationic short peptides of fewer than 30 amino acids, and oligoarginine-based CPPs with the length of 8—10 arginine residues have shown the most efficient membrane penetration [72].\nFrom the classic mechanism [72] the membrane penetration of CPPs is not associated with their self-assembly. Membrane penetration is based on the hydrogen bonding interaction between the guanidinium groups of arginine residues and the carboxyl, phosphoryl, or sulfuryl groups of the carbohydrates and phospholipids on the cell surface (Fig. 10). The pathway of CPP translocation through membranes was initially explained via receptor- and endocytosis-independent mechanisms. Recently a new CPP\nPlease cite this article in press as: N. Habibi, et al., Nano Today\ninternalization mechanism has been demonstrated which shows the role of self-assembly in ability of CPP peptides in traversing cell membranes [10].\ng d a c l c N t [\nu a ( l o i o M f d c l i\n( l i t a d t i r c n\nPRESS 11\nA third helix peptide (Antennapedia Homeodomain) was eported to translocate biological membranes. It was found hat after internalization into E15 rat embryos, the pepides were recovered as a multimeric complex. The results uggest that CPP could internalize through cell membranes ither in monomers or self-assembled aggregates. Moreover, ome important studies demonstrated that the retaining of heir conformation by CPPs after self-assembly is the key to heir membrane-penetrating abilities.\nThe effect of self-assembled aggregates on DNA encapulation and delivery has also been studied. Peptides such s 46 8 (LARLLARLLARLLARL) and Hel 11-7 (KLLKLLLKLKKLLKLLK) form aggregates with DNA and transfer DNA. owever, transfection efficiency was shown to be poor in he case of 46 12, when the peptide was not able to form ggregates. Aggregate formation also prevents DNA degraation.\nTirrell et al. used an amphiphilic peptide (Gly-Pro Hyp)4IV-H1] to modify PEG-coated liposomes in order to target ouse fibroblast cells. After incorporation of IV-H1 peptidemphiphile, they maintained their native triple-helical tructure and enhanced uptake of the IV-H1 modified lipoomes over non-targeted liposomes [73].\nDendrigraft poly-L-lysines (DGLs), a new kind of elf-assembled peptide containing lysine, was recently modfied by a peptide (sequence: EPRNEEK) derived from Streptococcus pneumoniae , a pathogen that causes meninitis. The modified peptide was used for targeted gene elivery to a glioma (brain tumor). The aim was to take dvantage of the process by which certain pathogens an cross the blood-brain barrier (BBB) in a transcelluar or paracellular manner. In vivo imaging results and ellular uptake indicated that EPRNEEK peptide-modified Ps enhanced brain tumor-targeting activity compared o a pentapeptide derived from endogenous laminin 33,74].\nArginine-rich peptides have also been designed and sed for enhanced cellular uptake. Sardan et al. designed n arginine-rich cell-penetrating amphiphilic peptide lauryl—PPPPRRRR—Am), which was integrated into a iposome formulation (DOPG) in order to target the activity f anticancer agents (doxorubicin-HCl and paclitaxel) nside MCF7 breast cancer cells. Arginine PA integrated n liposomes enhanced the uptake of model reagents by CF7 breast cancer cells compared to native liposomes and ree reagents [33]. Both hydrophilic (i.e., rhodamine and oxorubicin-HCl) and hydrophobic (i.e. paclitaxel) antiancer agents have been loaded in arginine-rich peptide iposomes in order to improve the uptake of both drugs nside cancer cells [33].\nStimuli-responsive supramolecular peptide-amphiphiles SPAs, dendritic poly(L-lysine) non-covalently linked poly(Leucine)) were synthesized with the ability to reassemble n lower pH for intracellular drug delivery. SPAS are shown o encapsulate guest molecules at pH 7.4 and release them t pH 6.2. In this way, SPAS can act as a smart platform to eliver their target to tumor cells with intracellular pH as a rigger. The nanovehicle was loaded with DOX and delivered\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nnside HepG2 cancer cells. Confocal scanning microscope esults indicated NVs can considerably enhance the endoytosis of DOX into HepG2 cells and deliver DOX to their uclei [75].\nIN PRESS+ModelN 1 N. Habibi et al.\nB c\nC o m a p b s e [ r m b\na m s g l a b p F i b\nw s n r t 7 r i\np g e s a\ns o w t s m l o i l t\no T s p L t a\nf\n[ [ a p a a d a\np i r b c b o t h f t s o s t s i b a n d t l c a t a b T\nARTICLEANTOD-496; No. of Pages 20 2\niomimetic membranes for model studies of ellular phenomena\nell interaction studies are usually performed with secndary molecules such as fluorescent probes. A biomimetic embrane allows one to study cell membrane signals nd interactions with ligands directly [9]. Self-assembled eptides play a significant role in fabrication of model iomimetic membranes. Short peptide sequences are a subtitution for ECM proteins. They mimic cell adhesion and liminate the complexity of ECM structural effects on cells 73]. In this regard peptide ligands have been incorpoated into biomaterials that can be used as biomimetic embranes. Examples are polyethylene glycol hydrogels, iodegradable copolymers, and SAMs [76].\nPAs, which contain an alkyl chain linked to a head group, lso represent an attractive alternative to biomimetic embranes. The alkyl chain of PAs has the capability to\nelf-assemble and mimic cell membranes, while the head roup sequence binds specifically with cell receptors. The ong alkyl chains of peptide-amphiphiles allow self-assembly nd interaction with other hydrophobic biomaterials. Active inding sites are available, since the orientation and comosition of molecules on the surface are well controlled. urthermore, these long chains can also improve the stabilty and activity of the peptide relative to the parent protein y protecting the secondary structure [9,77].\nEarlier studies on stimulation of ion channel membranes ere carried out using self-assembled -sheet cylindrical tructures. Cyclic peptide structures formed by an even umber of alternating D and L amino acids can adopt a flat ing shape to establish a connecting hollow tubular strucure. An assembly of 8 to 10 subunits with a distance of —5 Å could serve as an artificial ion channel membrane. The esults demonstrated that the effective channel mediated on transport at the rate of 107 ion/s.\nFurther studies have used model LB membranes comosed of peptide-amphiphiles and lipidated polyethylene lycol [68] to investigate the fundamental effects of pH, lectrostatic interactions, hydrogen bonding on bioadheion, ligand availability, cell spreading, and migration vailability.\nThe conformation presentation, organization, and accesibility of peptide ligands in LB films could be controlled, ffering valuable insights into cell adhesion. LB membranes ere mixed with lipidated polyethylene glycol and used o study the effect of ligand accessibility on cell adheion. The results showed that ligand accessibility plays a ajor role in cell adhesion to biomimetic membranes and igand-receptor interaction. [78]. Studies on LB membranes f triple-helical collagen mimetic peptides showed that varous head groups of PEG lipidated molecules with different ength could affect ligand accessibility and eventually conrol adhesion and spreading of melanoma cells [79].\nThe effect of conformation and orientation of RGD PA n cellular response was studied by Pakalns et al. [80]. he results revealed that looped RGD could support adheion and spreading of M14#5 human melanoma cells. RGD eptide motif and the synergy site PHSRN were placed in\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nB membranes, and the effect of their secondary strucure on cell adhesion, cell spreading, and integrin binding ffinity was investigated by Johnson, Kendall, Roberts (JKR)\na p s\nhe 18A peptide trimer in solution [86] Printed with permission\nrom RSC.\n81] and AFM collective studies. [69,78]. Dillow et al. 82] employed RGD (primary binding site for 5 1 integrin) nd PHSRN (the synergy binding site for 5 1 integrin) in eptide amphiphile membranes and investigated specific dhesive interactions between fibronectin-derived peptidemphiphiles. The result demonstrated that adhesion was ependent on membrane composition, density, and temperture, which affect peptide mobility.\nMost recently, self-assembling peptides have been romising tools for handling structural and functional studes of membrane-bound proteins such as G-protein-coupled eceptors (GPCRs). It is worth noting that abundant memrane proteins are vital for the functioning of biological ells. Almost 30% of the human genome codes for memrane proteins, which are principal targets for nearly 50% f medical drugs [83]. However, understanding their funcionality remains a challenge, and only a limited number of igh-resolution structural studies have been carried out so ar [84]. In 2012, the Nobel prize in Chemistry was awarded o Brian Kobilka and Robert Leowitz for their effort in undertanding several protein complexes from the important class f G-protein coupled receptors 3. New biomimetic materials uch as self-assembling proteins allow membrane proteins o organize in a 3D membrane lattice, opening new posibilities for their crystallization, biochemical studies, and ntegration in nanodevices [84]. Apoliprotein A1 (ApoA1)ased lipoprotein particles have been recently recognized s a new platform to study membrane proteins. In combiation with phospholipids, they can self-assemble to form iscoidal-shaped particles that can stabilize membrane proeins [85]. ApoA1 is the main constituent in high-density ipoproteins (HDLs) and is known to form discoidal partiles when associated with lipids. Midtgaard et al. examined n ApoA1 mimetic peptide referred to as A18, and its soluion structure [86]. A18 is an 18-amino-acid amphipathic -helical peptide of class A, assembled synthetically into icelles to mimic the in vivo properties of ApoA1 (Fig. 11.). wo approaches for incorporation of membrane proteins\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nre nanodisc and bicelles. Bicelles are two types of phosholipids that separate locally to make discoidal bilayer ystems. Although nanodiscs are shown to be more effective\nIN+Model\nf v c h t c a i u w [ t S f t a i a t\nb a n d f n r t w t t f p r t t t t t t n g c\ne c e E h t d c u c t w c\nARTICLENANTOD-496; No. of Pages 20 Self-assembled peptide-based nanostructures\nin the stabilization of membrane proteins, using bicelles is easier when handling proteins.\nTherefore, the focus of work by Midtgaard et al. [86] was to investigate whether A18 could provide the flexibility of bicelles along with the native membrane-like environment of nanodiscs. They observed that membrane proteins could be easily incorporated in 18A discs and maintain their stability.\nRecent studies also showed that self-assembling peptides could interact with proteins or protein assemblies in cells and could be selectively formed in certain cells, thus providing novel strategies to manipulate the fate of cells. Wang et al. developed self-assembling peptides with L- and D-amino acids (NBD-DFDFDYGLKKTETQ) and studied their biological functions in cells. Interestingly, the results demonstrated that the utilization of D-amino acids in self-assembling peptides boosts their cellular membrane localization [87]. D-amino acids were specially enriched in cellular membranes at self-assembled stages. However they were distributed uniformly in the cytoplasma of cells at unassembled stages. Wang et al. [87] demonstrated the possibility of using such D-amino acid-based peptides to engineer cell surfaces.\nMembrane interaction of a model -sheet self-assembled peptide, P11-2 (CH3CO-Gln-Gln-Arg-Phe-Gln-Trp-Gln-PheGlu-Gln-Gln-NH2), was studied by Salay et al. in order to mimic the toxicity and structural behavior of -amyloid peptide (A ) [88]. In Alzheimer’s disease -amyloid peptide (A ) is a main protein component of plaques. However its role in neurotoxicity is not fully understood. Model peptides could help evaluate the possible mechanisms of toxicity, which is common among self-assembling peptides associated with disease. The results confirmed that transitional oligomers had higher toxicity against cells than monomeric forms and higher aggregates of the peptide. Thus a rationally designed yet simple model -sheet peptide recapitulates a variety of the important features of A peptide function and structure. This supports the theory that toxicity arises from a common mode of action on membranes regardless of specific aspects of the sequence of amino acids.\nAnticancer drug delivery\nCancer is among the most widespread causes of death, and chemotherapy is still the most common treatment. However, conventional chemotherapy agents have tremendous disadvantages, as they can easily distribute nonspecifically in body tissue, causing damage to normal in addition to tumor cells. This induces nonspecific drug distribution in the body with severe systemic side effects, and therefore chemotherapy often results in an unsatisfactory curative effect due to the side effects of the drugs. Nanoparticles have been extensively used for delivery of anticancer drugs, as they can increase the efficacy of treatment and reduce undesirable side effects. Nanosized carriers offer advantages such as high drug-loading ability, improved stability by avoiding fast clearance by the reticuloendothelial and renal systems, and minimized drug loss during blood circulation [89].\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nAmong various nanosized carriers, self-assembled peptide nanostructures have gained attention for the delivery of anticancer agents and seem to be a promising approach for cancer treatment. Self-assembly mechanisms allow\nt d R n\nPRESS 13\normation of various types of nanoparticles such as tubes, esicles, and hydrogels, each suitable for delivery of speific types of anticancer agents. For example, injectable ydrogel formulations can be placed in direct contact with umor tissues and therefore improve the safety and effiacy of cancer treatment [47]. Nanotubes also have been pplied to load doxorubicin with high efficiency in their nner core [24]. Amphiphilic peptide nanovesicles have been sed for loading hydrophobic drugs in their alkyl core, hile the shell is modified to improve intracellular delivery 66]. Moreover, modifications have been applied to increase argeting activity and intracellular delivery efficacy [33]. everal self-assembled peptide structures have been used or loading anticancer agents, such as doxorubicin, pacliaxel, curcumin, and fluorouracil and studied in preclinical nd clinical trials, owing to their excellent biodegradabilty and biocompatibility. There have been several recent dvances in anticancer treatment using self-assembled pepides.\nStandley et al. designed a PA with highly cationic memrane lytic (Lysin) sequence (KLAKLAK)2 conjugated to lauryl cid (C16-A4G3(KLAKLAK)2) capable of forming cylindrical anofibers and disrupting cell membranes [90]. The results emonstrated that PA is more cytotoxic against the transormed cell membranes of cancer cells due to increased egative charge on these surfaces [91]. Moreover it was evealed that in addition to passive permeation, KALA epiope mediated uptake targeting [92]. A limitation associated ith these kinds of PAs, however, is rapid degradation of pepide after systematic delivery [93]. One tactic to enhance he therapeutic-delivery vehicle is to functionalize the surace with polymers such as PEG, which can protect from roteolysis, improve circulation time, and lessen immune esponse [94]. Furthermore, in 2012, Toft et al. introduced he use of cytotoxic KLAK PA and a co-assembled combinaion of pegylated PA (PEG PA) to make an effective antitumor herapy [95]. Addition of the pegylated PA to the nanostrucure limits degradation of the cytolytic PA by the protease rypsin. Systemic administration of cytotoxic pegylated PAs o an orthotopic mouse xenograft model of breast cancer sigificantly reduced tumor cell proliferation and overall tumor rowth, thus suggesting its effectiveness and versatility for ancer treatment.\nA study carried out in 2012 proposed molecular, lectrostatic interaction-based binding between EAK, a selfomplementary peptide and hydrophobic anticancer drug llipticine (EPT). EAK was able to increase the stability of PT in aqueous solution [96,97] at a concentration much igher than the drug’s solubility in water (∼0.62 M at neural pH) [98]. Furthermore, a fluorescence technique that ifferentiates the two molecular states (protonated and rystalline EPT in situ) was used to evaluate different moleclar states of EPT for its anticancer efficacy. An in vitro ytotoxicity assay has been applied to analyze the efficacy of he two molecular states of EPT, indicating that complexes ith protonated EPT had higher cytotoxicity than those with rystalline EPT [99].\nResearchers have also utilized micro- and nanopar-\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nicles containing self-assembled peptides conjugated to oxorubicin as an effective cancer treatment. In 2015, ubert pe rez et al. proposed hierarchical assembly of PA anofibers with alginate to shape micro-particles, in which\nIN+ModelN 1\nd s f w t e s [\nw p s t f a P N t o n f\nw w c o c\nt s a e c r s t F d a w t\na t t n D m t e t a c\nG\nD g h v i e\ng i s u c t f p p s b\nr S f d i b r u t i p\nr e c [ t c t a n i a b P b a\nC t t\nt p d 1 h s V f a a c t\ns\nARTICLEANTOD-496; No. of Pages 20 4\noxorubicin was conjugated to an alginate core, and the hell was constructed of peptide amphiphile nanofibers unctionalized to target the folate receptor. Folate groups ere covalently linked to C16-V3A3K3 via a lysine linker o target the doxorubicin-containing particles to cells overxpressing the folate receptor. The PA shell increased the urface-over-volume ratio to its ideal amount for targeting 6].\nFurthermore, hybrid NPs were made of low-moleculareight polylactide (PLA) [100] and self-assembling V6K2 eptides (VVVVVVKK) [101], which self-assembled into pherical nanoparticles with 100 nm as an average diameer. PLA-V6K2 were used to host doxorubicin and paclitaxel or cancer treatments, and their toxicity, release kinetics, nd cellular uptake were studied. The results revealed that LA-V6K2 NPs had much higher tumor cell uptake than PLA Ps that were stabilized with PEG (PLA-EG). This was due o the electrostatic interactions between the lysine groups f the peptide. The results indicated the greater efficacy of anoparticles functionalized with self-assembled peptides or cancer treatments [102].\nFurthermore, different self-assembled dipeptide NPs ith a non-protein amino acid, , dehydrophenylalanine ere used for entrapment of curcumin. The di-peptide curumin NPs could be assembled in a mixture of aqueous and rganic phase and enhanced the biological activity of curumin [103].\nLi et al. investigated dendrimer peptides with the strucure of glycyl-phenylalanyl-leucyl -glycine tetra-peptide pacer (Gly-Phe-Leu-Gly, GFLG) to host anti-cancer drugs as\nsuitable substrate for protease cathepsin B, which is an nzyme overexpressed in many tumor and tumor endothelial ells. GFLG peptide could be used to design smart enzymeesponsive drug-delivery vehicles. Fluorescence imaging tudies demonstrated that the nanoparticles can concenrate in tumors and be retained for a long period [104]. urthermore, multifunctional delivery platforms such as ual-functional liposomes with active targeting hyaluronic cid (HA) and pH-responsive cell-penetrating peptide (CPP) ere fabricated for enhancing the efficacy of tumorargeted cancer treatments [105]. Perhaps the most interesting application of selfssembled peptides for cancer treatment, however, is he injectable gel formulation, in which chemotherapeuic agents (unlike traditional chemotherapy) can be located ext to or into target tissues at higher local concentrations. ue to the slow rate of release, these formulations provide ore prolonged and sustained cytotoxic action than convenional chemotherapeutic agents, thus enhancing therapeutic fficacy. With this in mind, Yishay-Safranchik et al. verified he possible use of in situ-forming hydrogels made of selfssembled KLD motifs to tune or extend the release of the onventional cytotoxic drug (doxorubicin) [47].\nene delivery\nevelopment of non-viral vehicles for efficient delivery of enes is still requiring major improvements. Gene carriers\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nave to be well organized to overcome the limitations of ector gene delivery, such as poor uptake into cells, toxcity and immunogenic response, and short-lived transgene xpression [106]. Research behind the designing of advanced\nc o a m\nPRESS N. Habibi et al.\nene delivery vehicles has focused on improving characterstic of efficient loading, enhanced cellular delivery, and pecific delivery. Cationic nanoparticles have been maniplated and applied extensively due to their high loading apacity for nucleic acids, their ability to transfer through he cell membrane, and their ability to protect nucleic acids rom degradation. However, cationic formulations can have roblems in some applications in vivo, as they deal with roteins in biological fluids and nonspecifically with cells to hape aggregates, which can lead to toxicity as well as poor iodistribution and immune responses [107].\nPeptide-based self-assembled nanostructures also repesent a promising approach for efficient gene delivery. olid-phase methods enable precise control over peptide abrication at the molecular scale. Oligonucleotides can be elivered to the interior of cells through endocytosis followng the transition of self-assembled nanotubes into vesicles y changing the concentration of building blocks [108]. Thus, ecent developments in bio-inspired gene delivery vehicles se a combination of viral genomes and self-assembled pepides [109]. This framework highlights some of the advances n the development of viral vectors with self-assembly of eptide-engineered nanostructure.\nFor efficient delivery the vector must pass four criteia. The vector must target specific cell-surface receptors, fficiently protect DNA from degradation, deliver the DNA argo to the nucleus, and disrupt the endosomal membrane 110]. For this, cationic peptides could condense with DNA hrough electrostatic interactions. The most famous DNAondensing cationic peptide is L-lysine, which interacts with he negative charge of DNA phosphate. Poly-L-Lysine (PLL) is\nsynthetic peptide containing repeated lysine and a large umber of surface amines. It is capable of electrostatic nteraction with polyanions. The length of the peptide has\nstrong effect on its properties, such as the size and staility of DNA condensate. However, high-molecular-weight LLs exhibit high cytotoxicity, and PEGylation is known to e useful to increase circulation half-life of the complex nd avoid plasma protein binding.\nCPPs enable cellular uptake of various molecular cargos. PPs are known to be powerful tools in overcoming limitaions associated with gene delivery vehicles and are able to ransfer genes with endosomal escape.\nIn 1997, Morris et al. [111] used MPG-designed peptides o deliver oligonucleotides. MPG is a synthesized 27-residue eptide vector that contains both a hydrophobic domain, erived from the fusion sequence of HIV gp41 (residues —17: G-A-L-F-L-G-FL-G-A-A-G-S-T-M-G-A)K-R-K-V′, and a ydrophilic domain derived from the nuclear localization equence of SV40 T-antigen (residues 21—27: P-K-S-K-R-K). The hydrophobic domain is known to be essential both or its membrane fusion activity and structural stabilization, nd the hydrophilic domain is useful for improving permetion of the nucleus. An acetyl group at the N-terminus and a ysteamide group at the C-terminus were added to enhance he ability to cross the cell membrane.\nWhen MPG was combined with oligonucleotides in olution, they quickly shaped into a complex with tight non-\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\novalent interactions. This implies that binding between ligonucleotides and MPG occurs through electrostatic interctions. Efficient delivery of this complex into the nucleus of ammalian cells happens in about an hour. MPG shows high\nIN+Model\na s s n f\nt h w G E s f a a e a p d G w [ b d w a a t e p b c a i b t w o t c d R i\nl F H l F t t a t p\nt o t\nARTICLENANTOD-496; No. of Pages 20 Self-assembled peptide-based nanostructures\nattraction for single- and double-stranded oligonucleotides. Further studies were carried out to understand the mechanism of MPG peptides in gene delivery to mammalian cells [112]. The result revealed that a mutation in the nuclear localization sequence (NLS) of the SV40 antigen domain prevents the carrier from entering the nucleus, making it a highly useful tool for robust siRNA delivery into cell cytoplasm, which does not require nuclear entry. Targeting cyclin 1 in mouse tumor models validated the potential therapeutic utility of MPG for siRNA delivery in cancer treatment, and it was shown to inhibit tumor growth [113]. Cyclin B1 together with Cdk1 kinase forms the ‘mitosis-promoting factor’. This is essential for entry into and progression through mitosis.\nNew gene delivery carriers have been designed with an Nterminal stearylated (STR) nuclear localization signal (NLS), PKKKRKV. The aim was to overcome cell membrane and nuclear pores, and to improve gene delivery [114]. The inclusion of arginine facilitates DNA binding, histidine is used for endosomal escape, and hydrophobic residues enhance cellular uptake [115].\nTo achieve high transfection efficiency, non-viral lipopeptide transfection agents were designed with four different sections, including an alkyl chain, one cysteine, 1 to 4 histidines, and 1 to 3 lysine residues. The lipopeptides were designed to facilitate dimerization through the cysteine residues, DNA binding at neutral pH through charged lysine residues, and endosomal escape through weakly basic histidine residues [116].\nFurthermore, a new generation of CPPs was introduced by Crombez et al., namely CADY, based on a secondary amphipathic peptide that was capable of improving delivery into challenging suspensions and primary cell lines and forming stable complexes with siRNA. CADY is a 20-residue amphiphatic peptide with the structure Ac-GLWRALWRLLRSLWRLLWRA-cysteamide, which forms a helical structure. CADY was able to efficiently introduce siRNA into cells and lower the expression of GAPDH at both mRNA and protein levels [113]. Try and Arg were replaced in the structure of CADY, since Arg has been shown to enhance cellular entry of CPPs and improve electrostatic cell-surface interactions [117,118] and Try enhances cellular uptake of CPPs due to their capability of interacting with lipid/cholesterol molecules inside the membrane [119]. The helical conformation of CADY also plays a significant role in the process of cell penetration and interactions with the cell membrane.\nMulticomponents have been evaluated for gene delivery, since they can perform a series of tasks in the multi-step process of drug or gene delivery as well as cell targeting. A multicomponent gene carrier composed of numerous combinations of the CPP TAT peptide (amino acid 48—60 of the HIV TAT protein) (Gly-Arg-Lys-Lys- Arg-Arg-Gln-Arg-Arg-ArgPro-Pro-Gln), a lysine-based cationic dendrimer (DEN), and a nuclear localization signal coming from the SV40 Large T protein (Pro-Lys-Lys-Lys-Arg-Lys-Val) were evaluated for their potential to deliver DNA to human HeLa cells [120]. The function of DEN is to form condensed particles with\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nDNA, which is necessary for effective uptake [121]. TAT was used to promote uptake from cellular membranes [122], and finally NLS was used to improve nuclear translocation [123]. The most efficient particle for DNA delivery was shown to be\nf i r s\nPRESS 15\nmulticomponent of DEN, TAT, and NLS. A fusogenic agent uch as chloroquine was required to improve gene expresion. The results showed that the function of chloroquine is ot only to aid in endosomal escape, but also to protect DNA rom degradation [124].\nMoreover, synthetic peptides were constructed to mimic he fusogenic properties of virus-based peptides [125]. Peraps the most revolutionary synthetic peptide is the GALA, hich has pH-sensitive and amphiphilic properties. The ALA sequence consists of 30 amino acid residues (WEA ALA AL AEA LAE HLA EAL AEA LEA LAA) and has a repeating eries of Glu, Ala, Leu, and Ala. Therefore, at pH 7.4, GALA orms a coil structure due to repulsive interactions of negtively charged groups of Glu, while at pH 5, it forms an mphipathic helix due to a protonated Glu residue. GALA xhibits pH-responsive properties with membrane fusion ctivity at pH 5. Therefore, GALA can induce an assistive rocess to release drugs from endosomes, like other viruserived fusogenic peptides [126]. In terms of DNA delivery, ALA has limitations associated with its anionic properties, hich prevent formation of condensed particles with DNA 127]. A combination of GALA with cationic complexes has een proven successful as a multifunctional carrier for gene elivery. In this regard KALA was synthesized in which Glu as substituted with Lysine, making it possible to condense nd protect DNA. However when Lysine is present in high mounts, the responsive activity of the peptide compared o GALA, which is highly active in low pH, is altered. When xposed to the negative charge of the membrane, increased rotonation of KALA allows the peptide to permeate memranes. In contrast, in a low-pH environment, increased net harge disrupts -helical structures and impedes permetion. Endosomal agents should be active only at low pH n order to avoid disturbance of other membranes, and this ehavior contributes to the lack of specificity and toxicity of he peptide [128]. In order to overcome this limitation, KALA as modified, and Lysine was substituted with Arginine in rder to form complexes with DNA [109]. The so-called pepide referred to as RALA, was synthesized, and RALA-DNA omplexes were developed with pCMV-Red Firefly Luc. For istribution studies, pCMV-Red Firefly Luc or RALA/p pCMVed or Firefly Luc complexes were injected into a mouse and ts bio-distribution was imaged (Fig. 12).\nBiodistribution analysis has shown that naked DNA is ocalized at the site of injection, whereas RALA/pCMV-Red irefly Luc nanoparticles have been dispersed (Fig. 12i). owever, stronger gene expression was detected in the ungs and liver after systemic injection of RALA/pCMV-Red irefly Luc nanoparticles compared to empty vectors. The ransfection efficacy realized by the RALA/pDNA nanoparicles in vitro was comparable to commercial transfecting gents with significantly lower toxicity, thus demonstrating he effectiveness of RALA as a DNA delivery platform with otential to reach the clinic.\nAccording to studies using self-assembled peptide strucures as a platform for DNA delivery, the main function f the peptide is to form nanoparticles with DNA, faciliate the uptake of DNA intracellularly, enable cargo escape\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nrom endosomal vesicles, and prompt gene expression both n vitro and in vivo [74,110]. These findings have allowed esearchers to develop vectors with improved efficiency, pecificity, and safety. However, the use of peptides as\nPlease cite this article in press as: N. Habibi, et al., Nano Today (2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nARTICLE IN PRESS+ModelNANTOD-496; No. of Pages 20 16 N. Habibi et al.\nARTICLE IN PRESS+ModelNANTOD-496; No. of Pages 20 Self-assembled peptide-based nanostructures 17\nFigure 12 In vivo and ex vivo biodistribution of gene expression following administration of RALA/pCMV-Luc complexes. Representative images of pDNA (i) Dorsal; (ii) Harvested organs captured via IVIS imaging of C57BL/6 mice 2 and 7 days post administration g 50 nd, t\nP t t t b d b a c a a v b s t o\nof pCMV-Luc or RALA/pCMV-Luc N:P 10 nanoparticles containin (For interpretation of the references to color in this figure lege\ndelivery vectors is still in its infancy and has the potential to grow exponentially (Table 1).\nConclusion and future outlook\nThe examples presented in this review highlight the potential role of self-assembled peptides and their smart activity for advanced drug delivery. A major advantage of using selfassembled peptides is that in many cases the carrier is the therapeutic itself. Multiple functionalities could be included in a single self-assembled carrier, including targeting, cell permeation, endosomal escape motifs, release-responsive characteristics, and efficient ionic binding with therapeutic payloads. The benefits of peptide-based carriers are many, since peptides make up the most important signaling language in the ECM [6], and once the peptides self-associate\nPlease cite this article in press as: N. Habibi, et al., Nano Today\ninto defined aggregates, they gain the other important functions of a self-assembled nanostructure (e.g., nanotubes and nanofibers, etc.). In recent years, peptides have progressed from basic studies focused on introducing various\no p r o\ng. (N = 3 ± SEM) Printed with permission from ELSEVIER [109]. he reader is referred to the web version of this article.)\nAs and their self-assembly mechanisms to advanced studies hat test their function in in vitro systems and translaionally relevant in vivo models in order to develop novel herapies [6]. Based on these studies, many peptides have een studied or tested with in vivo model systems, and a iverse range of potential biological medical targets have een introduced. As building blocks, SAPs have significant dvantages in nanomedical applications due to their bioompatibility, responsiveness to environmental change, and bility to be functionalized with targeting ligands. These dvantages make SAPs essential elements for advanced inivo drug delivery applications. However, several issues must e addressed before clinical trials begin, including precise ize control during synthesis, stability of hydrophobic pepides in water-based solutions, and the long-term effects f nanosized structures on cells. For improving control\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nver the synthesized SAPs’ size, changes in the fabrication arameters or the use of templates could represent novel outes in obtaining highly reproducible nanostructures. In rder to enhance the stability of these self-assembled\nIN+ModelN 1\nn h s u t a i p p M f 1 i c w c a t p l s a c p e s t s p S a c h t d o t i t t\nA\nT H B t a\na b\nR\nARTICLEANTOD-496; No. of Pages 20 8\nanostructures in liquid-based solutions, studies in this field ave shown that changes in pH most likely increase the tability of FF aromatic diphenylalanine peptides in liqid solutions. However, future works should be directed owards a more complete study of the biocompatibility nd immunogenicity of this biomaterial in order to clarfy the consequences of exposure [7]. Two main routes for eptide synthesis are recombinant technology and solidhase chemical methods. Even the smallest-scale Good anufacturing Practices (GMP)-grade manufacturing lot by ermentation of a recombinant organism can cost over US$ million. The solid-phase method is still the manufacturng method of choice for peptide synthesis [42—44]. Current hallenges exist for manufacturing peptides at large scale, hich is essential for their clinical translation; additional hallenges include peptide impurities and failure to detect nd remove them chromatographically. Lack of regularity in he rules for defining peptide purity for therapeutic comounds and for synthesis of highly purified peptide might ead to loss of economic viability. The future outlook of elf-assembled peptides in the area of drug delivery is that\ngrowing number of peptide-based drugs will soon enter linical trials. There will likely be a massive upsurge in eptide formulations with PEG, CPP for intracellular delivry, and short-sequence peptides as carriers [141]. Similarly, everal self-assembled peptides with anti-bacterial properies are expected to enter clinical trials [18]. Furthermore, elf-assembled membrane-penetrating peptides have the otential to increase the number of intracellular targets. upramolecular hydrogelators formed from small peptides re already commercially available drugs that act both as arriers and the drug itself [37]. One of these hydrogelators as already been approved by FDA for clinical use [142]. In he future, peptides could act not only as the active ingreients of new drugs but as multifunctional ‘‘add-ons’’ to ther pharmaceutical agents to direct them to their targets, o ferry them across cellular membranes, and/or to modfy their biological action. In conclusion, we anticipate that he future for peptide-based self-assembled nanostructured herapeutic compounds is bright and promising.\ncknowledgments\nhis work was supported by the National Institute of ealth under award numbers R01AI118502 and F32AI102590; righam and Women’s Hospital and Harvard Medical School hrough Bright Futures Prize, Innovation Evergreen Fund, nd Fund to Sustain Research Excellence.\nThis work was also supported by the Scientific WAQF Fund t King Abdulaziz University (KAU), Jeddah under grant numer 17/1436.\neferences\n[1] G. Whitesides, J. Kriebel, B. Mayers, in: WTS (Ed.), Nanoscale Assembly: Chemical Techniques, Springer, Berlin, 2005, pp. 217—238.\nPlease cite this article in press as: N. Habibi, et al., Nano Today\n[2] T.H. Han, J. Kyun Oh, G.-J. Lee, S. Pyun, S. Kim, Colloids Surf., B: Biointerfaces 79 (2010) 440. [3] V.V. Korolkov, S. Allen, C.J. Roberts, Faraday Discuss 166 (2013) 257.\nPRESS N. Habibi et al.\n[4] T. Zohrabi, N. Habibi, Int. J. Pept. Res. Ther. (2015) 1—9, http://dx.doi.org/10.1007/s10989-015-9468-6. [5] X. Yan, P. Zhu, J. Li, Chem. Soc. Rev. 39 (6) (2010) 1877. [6] C.M. Rubert pe rez, N. Stephanopoulos, S. Sur, S. Lee, C.\nNewcomb, S. Stupp, Ann. Biomed. Eng. 43 (2015) 501. [7] J. Castillo-León, K.B. Andersen, W.E. Svendsen, in: Rosario\nPignatello (Ed.), Biomaterials Science and engineering, INTECH, Shanghai, 2011, pp. 115—138, Vols. [8] J.B. Matson, R. Helen Zha, S.I. Stupp, Curr. Opin. Solid State Mater. Sci. 15 (2011) 225—235. [9] E. Kokkoli, A. Mardilovich, A. Wedekind, E.L. Rexeisen, A. Garga, Soft Mater. 2 (2006) 1015—1024. [10] S. Pujals, J. Fernández-Carneado, C. López-Iglesias, Biochim. Biophys. Acta 1758 (2006) 264—279. [11] S.-J. Rymer, S.J.B. Tendler, C. Bosquillon, C. Washington, C.J. Roberts, Ther. Delivery 2 (2011) 1043—1056. [12] V.A. Kumar, N. Taylor, A. Jalan, L. Hwang, B. Wang, J. Hartgerink, Biomacromolecules 15 (2014) 1484—1490. [13] H. Cui, M. Webber, S. Stupp, Biopolymer 94 (2010) 1—18. [14] A.M. Smith, E.F. Banwell, W.R. Edwards, M.J. Pandya, D.N.\nWoolfson, Adv. Funct. Mater. 16 (8) (2006) 1022—1030. [15] C. Fishwick, A.J. Beevers, L.M. Carrick, C.D. Whitehouse, A.\nAggeli, N. Boden, Nano Lett. 11 (3) (2003) 1475—1479. [16] J. Schneider, D. Pochan, B. Ozbas, J. Am. Chem. Soc. 124\n(2002) 15030—15037. [17] D.A. Salick, J.K. Kretsinger, D.J. Pochan, J.P. Schneider, J.\nAm. Chem. Soc. 129 (47) (2007) 14793—14799. [18] L. Liu, K. Xu, H. Wang, P.K. Jeremy Tan, W. Fan, S.S. Venka-\ntraman, et al., Nat. Nanotechnol. 4 (2009) 457—463. [19] G. Di Lullo, S. Sweeney, J. Korkko, L. Ala-Kokko, J. San Anto-\nnio, J. Biol. Chem. 277 (6) (2002) 4223—4231. [20] H. Janice Leea, J. Leea, T. Chansakula, C. Yua, J. Elisseeffa,\nS. Yu, Biomaterials 27 (30) (2006) 5268—5276. [21] J.D. Hartgerink, E. Beniash, S.I. Stupp, Science 294 (2001)\n1684—1687. [22] C.H. Gorbitz, Chem. Commun. 22 (2006) 2332—2334. [23] M. Reches, E. Gazit, Phys. Biol. 3 (1) (2006) 10. [24] F.R. Silva, D.R. Araujo, E. Silva, R.A. Ando, W. Alves, Langmuir\n29 (2013) 10205—10212, 2013. [25] X. Yan, Y. Cui, Q. He, K. Wang, J. Li, W. Mu, et al., Chem. Eur.\nJ. 14 (2008) 5974—5980. [26] T. Kunitake, Angew. Chem. Int. Ed. 31 (6) (1992) 709—726. [27] S. Santoso, W. Hwang, H. Hartman, S. Zhang, Nano Lett. 2 (7)\n(2002) 687—691. [28] H. Cui, T. Muraoka, A. Cheetham, S. Stupp, Nano Lett. 9 (3)\n(2009) 945—951. [29] N. Bertranda, J. Wub, X. Xua, N. Kamalyb, O.C. Farokhzad,\nAdv. Drug Delivery Rev. 66 (2014) 2—25. [30] Y.S. Velichko, S. Stupp, M.O. De la Cruz, J. Phys. Chem. B 112\n(8) (2008) 2326—2334. [31] S. Zhang, M.A. Greenfield, A. Mata, L.C. Palmer, R. Bitton,\nJ.R. Mantei, et al., Nat. Mater. 9 (7) (2010) 594—601. [32] J. Fernandez-Carneado, M. Kogan, N. Van Mau, S. Pujals,\nS. pez-Iglesias, F. Heitz, et al., J. Pept. Res. 65 (6) (2005) 580—590. [33] M. Sardan, M. Kilinc, R. Genc, A.B. Tekinay, M.O. Guler, Faraday Discuss 166 (2013) 269—283. [34] J.B. Matson, C.J. Newcomb, R. Bitton, S.I. Stupp, Soft Mater. 8 (13) (2012) 3586—3595. [35] S. Zhang, F. Gelain, X. Zhao, Semin. Cancer Biol. 15 (2005) 413—420. [36] S. Zhang, T. Holmes, C. Lockshin, A. Rich, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3334—3338. [37] F. Zhao, M.L. Mab, B. Xu, Chem. Soc. Rev. 38 (2009)\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\n883—891. [38] S. Fleming, R. Ulijn, Chem. Soc. Rev. 43 (2014) 8150—8177. [39] C. Valery, Proc. Natl. Acad. Sci. U.S.A. 100 (2003)\n10258—10262.\nIN+Model\n[\n[\n[\n[\n[\n[\n[\n[\n[\nARTICLENANTOD-496; No. of Pages 20 Self-assembled peptide-based nanostructures\n[40] Z. Yang, G. Liang, B. Xu, Acc. Chem. Res. 41 (2008) 315—326. [41] M. Zhou, R.V. Ulijn, J.E. Gough, J. Tissue Eng. (2014),\nhttp://dx.doi.org/10.1177/2041731414531593 (in press). [42] J.M. Palomo, RSC Adv. 4 (2014) 32658—32672. [43] R.B. Merrifield, J. Am. Chem. Soc. 85 (1963) 2149. [44] R. Lax, Int. Pep. Rev. (2011) 1—15. [45] J. Elisseeff, Expert Opin. Biol. Ther. 4 (12) (2004) 1849—1859. [46] Q. Hou, P. De Bank, K. Shakesheff, J. Mater. Chem. 14 (2004)\n1915—1923. [47] E. Yishay-Safranchik, M. Golana, A. David, Polym. Adv. Tech-\nnol. 25 (2014) 539—544. [48] A. Hoffman, Adv. Drug Delivery Rev. 54 (2002) 3—12. [49] J. Schneider, D. Pochan, B. Ozbas, R. Karthikan, L. Pakstis, J.\nkrestsinger, J. Am. Chem. Soc. 124 (2002) 15030—15037. [50] Y. Nagai, L.D. Unsworth, S. Koutsopoulos, S. Zhang, J. Control.\nRelease. 115 (2006) 18—25. [51] J. Kisiday, M. Jin, B. Kurz, H. Hung, C. Semino, S. Zhang, et al.,\nProc. Natl. Acad. Sci. U.S.A. 99 (15) (2002) 9996—10001. [52] B. Law, R. Weissleder, C.H. Tung, Biomacromolecules 7 (4)\n(2006) 1261—1265. [53] S. Koutsopoulosa, L. Unswortha, Y. Nagaia, S. Zhang, Proc.\nNatl. Acad. Sci. U.S.A. 106 (12) (2008) 4623—4628. [54] F.-C. Alicia, F.J. Arias, M. Alonso, J.C. Rodríguez-Cabello,\nBiomacromolecular 5 (2013) 1456—1468. [55] R. Machado, A.D. Costa, V. Sencadas, C. Garcia-Arévalo,\nC.M. Costa, J.P. Gomes, et al., Biomed. Mater. 14 (2014) 1587—1595. [56] I.G.D. Torre, M. Santos, L. Quintanilla, A. Testera, M. Alonso, J.C.R. Cabello, Acta Biomater. 10 (6) (2014) 2495—2505. [57] A. Altunbus, Biomaterials 32 (25) (2011) 5906—5914. [58] Y.F. Tian, G.A. Hudalla, H. Hana, J.H. Collier, Biomater. Sci.\n1 (2013) 1037—1045. [59] X. Li, J. Li, Y. Gao, Y. Kuang, J. Shi, B. Xu, J. Am. Chem. Soc.\n132 (50) (2010) 17707—17709. [60] L. Mao, H. Wang, M. Tan, L. Ou, D. Kongab, Z. Yang, Chem.\nCommun. 48 (2012) 395—397. [61] H. Wang, L. Lv, G. Xu, C. Yang, J. Sun, Z. Yang, J. Mater. Chem.\n22 (2012) 16933—16938. [62] H. Wangab, Z. Yang, Soft Matter 8 (2012) 2344—2347. [63] M.R. Reithofer, K.-H. Chan, A. Lakshmanan, D.H. Lam, A.\nMishra, B. Gopalan, et al., Chem. Sci. 5 (2014) 625—630. [64] M. Briuglia, A. Urquhart, D. Lamprou, Int. J. Pharm. 474\n(2014) 103—111. [65] A. Garg, A.W. Tisdale, E. Haidari, E. Kokkoli, Int. J. Pharm.\n366 (2009) 201—210. [66] B. Job, R.H. Zha, F. Tantakitti, E. Zhuang, R. Zandi, C.J. New-\ncomba, et al., RSC Adv. 5 (2015) 8753—8756. [67] N. Habibi, L. Pastorino, F. Soumetz, F. Sbrana, R. Raiteri, C.\nRuggiero, Colloids Surf., B: Biointerfaces 88 (2011) 366—372. [68] Y. Dori, H. Bianco-Peled, S.K. Satija, G.B. Fields, M. Tirrell,\nJ. Biomed. Mater. Res. 50 (2000) 75—81. [69] A. Mardilovich, J. Craig, M. McCammon, A. Garg, E. Kokkoli,\nLangmuir 22 (2006) 3259—3264. [70] M. Magzoub, A. Graslund, Q. Rev. Biophys. 37 (2) (2004)\n147—195. [71] B. Gupta, T. Levchenko, V. Torchilin, Adv. Drug Delivery Rev.\n57 (2005) 637—651. [72] S.M. Fuchs, R.T. Raines, Cell. Mol. Life Sci. 63 (16) (2006)\n1819—1822. [73] M. Tirrell, E. Kokkoli, M. Biesalski, Surf. Sci. 500 (1—3) (2002)\n61—68. [74] Y. Liu, X. He, Y. Kuang, S. An, C. Wang, Y. Guo, et al., Mol.\nPharm. 11 (2014) 3330—3341.\nPlease cite this article in press as: N. Habibi, et al., Nano Today\n[75] X. Xu, Y. Li, H. Li, R. Liu, M. Sheng, B. Bin He, Small 10 (6) (2014) 1133—1140. [76] L. Pastorino, N. Habibi, F. Soumetz, M. Giulianelli, C. Ruggiero, Eur. Cell Mater. 22 (2011) 66.\n[\nPRESS 19\n[77] N.A. Lockwood, J.R. Haseman, M. Tirrell, K.H. Mayo, Biochem. J. 378 (2004) 93—103. [78] A. Mardilovich, E. Kokkoli, Biomacromolecules 5 (2004) 950—957. [79] S.E. Ochsenhirt, E. Kokkoli, J.B. McCarthy, M.M. Tirrell, Biomaterials 27 (2006) 3863—3874. [80] T. Pakalns, K.L. Haverstick, G.B. Fields, J.B. McCarthy, D.L. Mooradian, M. Tirrell, Biomaterials 20 (1999) 2265—2279. [81] J.K. Loius, Mechanics of Contact Interaction, Press syndicate of the university of cambridge, Moscow, 1987. [82] A.K. Dillow, S.E. Ochsenhirt, J.B. McCarthy, G.B. Fields, M. Tirrell, Biomaterials 22 (2001) 1493—1505. [83] M.A. Yildirim, K.-I. Goh, M.E. Cusick, A.-L. Barab, M. Vidal, Nat. Biotechnol. 25 (10) (2007) 1119—1126. [84] S. Zhang, Nat. Biotechnol. 21 (2003) 10—16. [85] T. Ritchie, Y. Grinkova, T. Bayburt, I. Denisov, J. Zolner-\nciks, W.M. Atkins, et al., Methods Enzymol. 464 (11) (2009) 64011—64018. [86] S.R. Midtgaard, M.C. Pedersen, J.J. Kain Kirkensgaard, K.K. Sørensen, K. Mortensen, K.J. Jensen, et al., Soft Matter 10 (2014) 738—752. [87] H. Wang, Y. Wang, A. Han, Y. Cai, N. Xiao, L. Wang, et al., ACS Appl. Mater. Interfaces 6 (2014) 9815—9821. [88] L.C. Salay, K.B. Wei Qi, L. Tamm, E. Fernandez Luiz, Biochim. Biophys. Acta 1788 (2009) 1714—1721. [89] J. Shi, Z. Xiao, N. Kamaly, O.C. Farokhzad, Acc. Chem. Res. 44 (10) (2011) 1123—1134. [90] S.M. Standley, D.J. Toft, H. Cheng, S. Soukasene, J. Chen, S.M. Raja, V. Band, H. Band, V.L. Cryns, S.I. Stupp, Pept. Cancer Res. 70 (2010) 3020—3026. [91] N. Papo, Y. Shai, Biochemistry 42 (2003) 9346—9354. [92] N.R. Soman, S.L. Baldwin, G. Hu, J.N. Marsh, G.M.\nLanza, J.E. Heuser, et al., J. Clin. Invest. 119 (2009) 2830—2842. [93] D.P. McGregor, Curr. Opin. Pharmacol. 8 (2008) 616—619. [94] M.J. Joralemon, S. McRae, T. Emrick, Chem. Commun. 46\n(2010) 1377—1393. [95] D.J. Toft, T.J. Moyer, S.M. Standley, Y. Ruff, A. Ugolkov, ASC\nNano 6 (9) (2012) 7956—7965. [96] S. Fung, H. Yang, P. Chen, Colloids Surf., B: Biointerfaces 55\n(2) (2007) 200—211. [97] B.S. Yu Fung, H. Yang, P.T. Bhola, P. Sadatmousavi, E. Muzar,\nM. Liu, P. Chen, Adv. Funct. Mater. 19 (2009) 74—83. [98] J. Liu, Y. Xiao, C. Allen, J. Pharm. Sci. 93 (1) (2004) 132—143. [99] S. Lu, H. Wang, Y. Sheng, M. Liu, P. Chen, J. Control. Release\n160 (2012) 33—40. 100] N. Nishiyama, K. Kataoka, Pharmacol. Ther. 112 (3) (2003)\n630—648. 101] G.V. Maltzahn, S. Vauthey, S. Santoso, S. Zhang, Langmuir 19\n(10) (2003) 4332—4337. 102] E. Jabbari, X. Yang, S. Moeinzadeh, X. He, Eur. J. Pharm.\nBiopharm. 84 (2013) 49—62. 103] S. Alam, J.J. Panda, V.S. Chauhan, Int. J. Nanomed. 7 (2012)\n4207—4222. 104] N. Li, N. Li, Q. Yi, K. Luo, C. Guo, D. Pan, et al., Biomaterials\n35 (2014) 9529—9545. 105] T. Jiang, Z. Zhang, Y. Zhang, H. Lv, J. Zhou, C. Li, et al.,\nBiomaterials 3 (2012) 9246—9258. 106] C.E. Thomas, A. Ehrhardt, M.A. Kay, Nat. Rev. 4 (2003)\n346—358. 107] B. Ballarin-Gonzalez, K. Howard, Adv. Drug Delivery Rev. 64\n(2012) 1717—1729. 108] X.H. Yan, Q. He, K. Wang, L. Duan, L. Cui, J. Li, Angew. Chem.\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nInt. Ed. 46 (2007) 2431—2434. 109] H.O. McCarthya, J. McCaffrey, C.M. McCruddena, A.\nZholobenkoa, A. Ali, J.W. Mcbride, et al., J. Control. Release 189 (2014) 141—149.\nIN+ModelN 2\n[ [\n[\n[\n[\n[ [\n[\n[\n[\n[\n[\n[ [\n[\n[\n[\n[\n[\n[ [\n[\n[\n[\n[\n[\n[\n[\n[\n[\n[\n[\n[\ns\nf t w t D\nt M c c n d m\ni d h World Report, Med Device Online, Popular Science, Device Space,\nARTICLEANTOD-496; No. of Pages 20 0\n110] E. Martin, K. Rice, AAPS J. 9 (1) (2007) 18—29. 111] M. Morris, P. Vidal, L. Chaloin, F. Heitz, G. Divita, Nucl. Acids\nRes. 25 (14) (1997) 2730—2736. 112] F. Simeoni, M.C. Morris, F. Heitz, G. Divita, Nucl. Acids Res.\n31 (11) (2003) 2717—2724. 113] L. Crombez, M.C. Morris, S. Dufort, G. Aldrian-Herrada, Q.\nNguyen, M.C.G.9815 Master, Nucl. Acids Res. 37 (14) (2009) 4559—4569. 114] H. Wang, J. Chen, Y. Sun, J. Deng, C. Li, X. Zhang, et al., J. Control. Release 155 (1) (2011) 26—33. 115] W.Y. Seow, Y.-Y. Yang, Adv. Mater. 21 (2009) 86—90. 116] J.A. Tarwadi, R.J. Jazayeri, R.J. Prankred, C.W. Pouton, Bio-\nconjug. Chem. 19 (2008) 940—950. 117] S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda,\net al., J. Biol. Chem. 276 (8) (2001) 5836—5840. 118] P. Wender, D. Mitchell, K. Pattabiraman, E. Pelkey, L. Stein-\nman, J. Rothbard, Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 13003—13008. 119] D. Derossi, A. Joliot, G. Chassaing, A. Prochiantz, J. Biol. Chem. 269 (14) (1994) 10444—10450. 120] D. Coles, S. Yang, A. Esposito, D. Mitchell, R. Minchin, I. Toth, Tetrahedron 63 (49) (2007) 12207—12214. 121] A. Mann, R. Richa, M. Ganguli, J. Control. Release 125 (3) (2008) 252—262. 122] M. Zhao, R. Weissleder, Med. Res. Rev. 24 (1) (2004) 1—12. 123] A. Eguchi, H. Furusawa, A. Yamamoto, T. Akuta, M. Hasegawa,\nY. Okahata, et al., J. Control. Release 4 (3) (2005) 507—519. 124] S. Yang, D.J. Coles, A. Esposito, D.J. Mitchell, I. Toth, R.F.\nMinchin, J. Control. Release 135 (2009) 159—165. 125] Y. Nishimura, K. Takeda, R. Ezawa, J. Ishii, C. Ogino, A. Kondo,\nJ. Nanobiotechnol. (2014), http://dx.doi.org/10.1186/ 1477-3155-12-11 (in press). 126] S. Futaki, Y. Masui, I. Nakase, Y. Sugiura, T. Nakamura, K. Kogure, et al., J. Gene Med. 7 (11) (2005) 1450—1458. 127] N.P.R. Subbarao, F. Szoka, L. Nadasdi, K. Pongracz, Biochem 26 (11) (1987) 2964—2972. 128] A. Erazo-Oliveras, M. Muthukrishnan, R. Baker, T. Wang, J. Pellois, Pharmaceuticals 5 (11) (2012) 1177—1209. 129] E. Gazit, Chem. Soc. Rev. 36 (2007) 1263—1269. 130] J. Matson, C. Newcomb, R. Bitton, S. Stupp, Soft Matter 8 (13)\n(2012) 3586—3595. 131] G.A. Silva, C. Czeisler, K.L. Niece, E. Beniash, D.A. Harring-\nton, J.A. Kessler, et al., Science 303 (2004) 1352—1355. 132] Y. Zhao, M. Tanaka, T. Kinoshita, M. Higuchi, T. Tan, J. Control.\nRelease 147 (3) (2010) 392—399. 133] Y. Wu, P. Sadatmousavi, R. Wang, S. Lu, Y.-F. Yuan, P. Chen,\nInt. J. Nanomed. 7 (2012) 3221—3233. 134] D. Mandal, A.N. Shirazi, K. Parang, Org. Biomol. Chem. 12\n(2014) 3544—3561. 135] H. Liu, J. Chen, Q. Shen, W. Fu, W. Wu, Mol. Pharm. 7 (6)\n(2010) 1985—1994. 136] S. Lv, M. Li, Z. Tang, W. Song, H. Sun, H. Liu, et al., Acta\nBiomater. 9 (12) (2013) 9330—9342. 137] W. Liu, J. McDaniel, X. Li, D. Asai, F.G. Quiroz, J. Schaal,\net al., Cancer Res. 72 (22) (2012) 5956—5965. 138] V. Marchi-Artzner, B. Lorz, U. Hellerer, M. Kantlenher, E.\nKessler, H. Sackmann, Chemistry 7 (5) (2001) 1095—1100. 139] P. Berndt, G.B. Fields, M. Tirrell, J. Am. Chem. Soc. 117 (1995)\n9515—9522. 140] D. Baronas-Lowell, J.L. Lauer-Fields, J.A. Borgia, G.F. Sfer-\nrazza, M. Al-Ghoul, D. Minond, et al., J. Biol. Chem. 279 (42) (2004) 43503—43513. 141] M. Davis, J. Motion, D. Narmoneva, T. Takahashi, D. Hakuno,\nPlease cite this article in press as: N. Habibi, et al., Nano Today\nR. Kamm, et al., Circulation 111 (4) (2005) 442—450. 142] M.C. Valery, B. Paternostre, T. Robert, T. Gulik-Krzywicki, J.C.\nNarayanan, G. Dedieu, et al., Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10258—10262.\nP r A\nPRESS N. Habibi et al.\nDr. Neda Habibi received her Bachelor’s and Master’s degrees from Isfahan University of Technology, Iran in 2007 and 2009, respectively. She also received her Ph.D. in Nanotechnology from University of Genova, Italy in 2012. Her PhD was focused on developing nanoengineered polymeric based capsules as drug delivery carriers with targeting activities. She is an Assistant Professor at Isfahan University of Technology. Her research interests include drug delivery, biomaterials,\nelf-assembled systems, and nanomedicine.\nNazila Kamaly is an instructor at Harvard Medical School (HMS) and Brigham and Women’s Hospital (BWH). She received her combined Bachelor’s and Master’s degrees in medicinal chemistry from University College London and completed her Ph.D. on the development of theranostic nanoparticles at the Department of Chemistry at Imperial College London in 2008. She was a postdoctoral fellow at HMS/BWH and Imperial College London prior to her current position. Her research is\nocused on the development of multifunctional nanoparticles for herapeutic and imaging applications in a number of diseases. She ill be taking up an Associate Professor (Seniorforsker) position in he Department of Nanotech at the Danish Technical University in enmark next.\nAdnan Memic graduated summa cum laude with a BSc in Chemistry and minor in Biology. He received his Ph.D. in Chemistry/Biochemistry from Wayne State University with Mark Spaller. He was a postdoctoral fellow in Chicago with Brian Kay at the University of Illinois. He was previously a visiting assistant professor of toxicology and pharmacology at Dartmouth Geisel Medical School. He joined King Abdulaziz University in 2010, was promoted to associate professor of nano-\nechnology and is concurrently a Lecturer on Medicine at Harvard edical School. His research focuses on bioactive molecule disovery, and includes the design and development of biomaterials, hemical and peptide analog libraries, protein and antibody engieering towards solving challenges in targeted drug delivery, evelopment of biosensors, and tissue engineering and regenerative edicine applications.\nDr. Hadi Shafiee is a faculty member at the Division of Bioengineering and Renal Division of Medicine at Brigham and Women’s Hospital, Harvard Medical School. He received his Bachelor’s and Master’s degrees in mechanical engineering from Isfahan University of Technology and University of Tehran, Iran in 2001 and 2003, respectively. He received his Ph.D. in engineering science and mechanics from Virginia Polytechnic Institute and State University in 2010. His research interest is\nntegrating biology/medicine with micro and nanotechnology to evelop innovative tools to solve unmet clinical problems. His work as been recognized by Science daily, Nature World News, Science\n(2016), http://dx.doi.org/10.1016/j.nantod.2016.02.004\nroduct Design & Development, HCP Live, Small, etc. Dr. Shafiee eceived 2014 Bright Futures Prize and 2015 Innovation Evergreen ward from Harvard Medical School."
    } ],
    "references" : [ {
      "title" : "B",
      "author" : [ "G. Whitesides", "J. Kriebel" ],
      "venue" : "Mayers, in: WTS (Ed.), Nanoscale Assembly: Chemical Techniques, Springer, Berlin",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "S",
      "author" : [ "T.H. Han", "J. Kyun Oh", "G.-J. Lee", "S. Pyun" ],
      "venue" : "Kim, Colloids Surf., B: Biointerfaces 79 ",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "S",
      "author" : [ "V.V. Korolkov" ],
      "venue" : "Allen, C.J. Roberts, Faraday Discuss 166 ",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Int",
      "author" : [ "T. Zohrabi", "N. Habibi" ],
      "venue" : "J. Pept. Res. Ther. ",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chem",
      "author" : [ "X. Yan", "P. Zhu", "J. Li" ],
      "venue" : "Soc. Rev. 39 (6) ",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Curr",
      "author" : [ "J.B. Matson", "R. Helen Zha", "S.I. Stupp" ],
      "venue" : "Opin. Solid State Mater. Sci. 15 ",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Soft Mater",
      "author" : [ "E. Kokkoli", "A. Mardilovich", "A. Wedekind", "E.L. Rexeisen", "A. Garga" ],
      "venue" : "2 ",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Biochim",
      "author" : [ "S. Pujals", "J. Fernández-Carneado", "C. López-Iglesias" ],
      "venue" : "Biophys. Acta 1758 ",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Ther",
      "author" : [ "S.-J. Rymer", "S.J.B. Tendler", "C. Bosquillon", "C. Washington", "C.J. Roberts" ],
      "venue" : "Delivery 2 ",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "J",
      "author" : [ "V.A. Kumar", "N. Taylor", "A. Jalan", "L. Hwang", "B. Wang" ],
      "venue" : "Hartgerink, Biomacromolecules 15 ",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "S",
      "author" : [ "H. Cui", "M. Webber" ],
      "venue" : "Stupp, Biopolymer 94 ",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Adv",
      "author" : [ "A.M. Smith", "E.F. Banwell", "W.R. Edwards", "M.J. Pandya", "D.N. Woolfson" ],
      "venue" : "Funct. Mater. 16 (8) ",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Nano Lett",
      "author" : [ "C. Fishwick", "A.J. Beevers", "L.M. Carrick", "C.D. Whitehouse", "A. Aggeli", "N. Boden" ],
      "venue" : "11 (3) ",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Chem",
      "author" : [ "J. Schneider", "D. Pochan", "B. Ozbas", "J. Am" ],
      "venue" : "Soc. 124 ",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "Chem",
      "author" : [ "D.A. Salick", "J.K. Kretsinger", "D.J. Pochan", "J.P. Schneider", "J. Am" ],
      "venue" : "Soc. 129 (47) ",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "W",
      "author" : [ "L. Liu", "K. Xu", "H. Wang", "P.K. Jeremy Tan" ],
      "venue" : "Fan, S.S. Venkatraman, et al., Nat. Nanotechnol. 4 ",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Chem",
      "author" : [ "G. Di Lullo", "S. Sweeney", "J. Korkko", "L. Ala-Kokko", "J. San Antonio", "J. Biol" ],
      "venue" : "277 (6) ",
      "citeRegEx" : "19",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "S",
      "author" : [ "H. Janice Leea", "J. Leea", "T. Chansakula", "C. Yua", "J. Elisseeffa" ],
      "venue" : "Yu, Biomaterials 27 (30) ",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "E",
      "author" : [ "J.D. Hartgerink" ],
      "venue" : "Beniash, S.I. Stupp, Science 294 ",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2001
    }, {
      "title" : "Chem",
      "author" : [ "C.H. Gorbitz" ],
      "venue" : "Commun. 22 ",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Phys",
      "author" : [ "M. Reches", "E. Gazit" ],
      "venue" : "Biol. 3 (1) ",
      "citeRegEx" : "23",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "W",
      "author" : [ "F.R. Silva", "D.R. Araujo", "E. Silva", "R.A. Ando" ],
      "venue" : "Alves, Langmuir 29 ",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "W",
      "author" : [ "X. Yan", "Y. Cui", "Q. He", "K. Wang", "J. Li" ],
      "venue" : "Mu, et al., Chem. Eur. J. 14 ",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Angew",
      "author" : [ "T. Kunitake" ],
      "venue" : "Chem. Int. Ed. 31 (6) ",
      "citeRegEx" : "26",
      "shortCiteRegEx" : null,
      "year" : 1992
    }, {
      "title" : "Nano Lett",
      "author" : [ "S. Santoso", "W. Hwang", "H. Hartman", "S. Zhang" ],
      "venue" : "2 (7) ",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "Nano Lett",
      "author" : [ "H. Cui", "T. Muraoka", "A. Cheetham", "S. Stupp" ],
      "venue" : "9 (3) ",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Adv",
      "author" : [ "N. Bertranda", "J. Wub", "X. Xua", "N. Kamalyb", "O.C. Farokhzad" ],
      "venue" : "Drug Delivery Rev. 66 ",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "S",
      "author" : [ "Y.S. Velichko" ],
      "venue" : "Stupp, M.O. De la Cruz, J. Phys. Chem. B 112 (8) ",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "R",
      "author" : [ "S. Zhang", "M.A. Greenfield", "A. Mata", "L.C. Palmer" ],
      "venue" : "Bitton, J.R. Mantei, et al., Nat. Mater. 9 (7) ",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "S",
      "author" : [ "J. Fernandez-Carneado", "M. Kogan", "N. Van Mau", "S. Pujals" ],
      "venue" : "pez-Iglesias, F. Heitz, et al., J. Pept. Res. 65 (6) ",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "R",
      "author" : [ "M. Sardan", "M. Kilinc" ],
      "venue" : "Genc, A.B. Tekinay, M.O. Guler, Faraday Discuss 166 ",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Soft Mater",
      "author" : [ "J.B. Matson", "C.J. Newcomb", "R. Bitton", "S.I. Stupp" ],
      "venue" : "8 (13) ",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Semin",
      "author" : [ "S. Zhang", "F. Gelain", "X. Zhao" ],
      "venue" : "Cancer Biol. 15 ",
      "citeRegEx" : "35",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Proc",
      "author" : [ "S. Zhang", "T. Holmes", "C. Lockshin", "A. Rich" ],
      "venue" : "Natl. Acad. Sci. U.S.A. 90 ",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 1993
    }, {
      "title" : "Chem",
      "author" : [ "F. Zhao", "M.L. Mab", "B. Xu" ],
      "venue" : "Soc. Rev. 38 (2009) ",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Chem",
      "author" : [ "S. Fleming", "R. Ulijn" ],
      "venue" : "Soc. Rev. 43 ",
      "citeRegEx" : "38",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Proc",
      "author" : [ "C. Valery" ],
      "venue" : "Natl. Acad. Sci. U.S.A. 100 ",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Acc",
      "author" : [ "Z. Yang", "G. Liang", "B. Xu" ],
      "venue" : "Chem. Res. 41 ",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "J",
      "author" : [ "M. Zhou", "R.V. Ulijn", "J.E. Gough" ],
      "venue" : "Tissue Eng. ",
      "citeRegEx" : "41",
      "shortCiteRegEx" : null,
      "year" : 1593
    }, {
      "title" : "RSC Adv",
      "author" : [ "J.M. Palomo" ],
      "venue" : "4 ",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Chem",
      "author" : [ "R.B. Merrifield", "J. Am" ],
      "venue" : "Soc. 85 ",
      "citeRegEx" : "43",
      "shortCiteRegEx" : null,
      "year" : 1963
    }, {
      "title" : "Int",
      "author" : [ "R. Lax" ],
      "venue" : "Pep. Rev. ",
      "citeRegEx" : "44",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Expert Opin",
      "author" : [ "J. Elisseeff" ],
      "venue" : "Biol. Ther. 4 (12) ",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Chem",
      "author" : [ "Q. Hou", "P. De Bank", "K. Shakesheff", "J. Mater" ],
      "venue" : "14 ",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Polym",
      "author" : [ "E. Yishay-Safranchik", "M. Golana", "A. David" ],
      "venue" : "Adv. Technol. 25 ",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Adv",
      "author" : [ "A. Hoffman" ],
      "venue" : "Drug Delivery Rev. 54 ",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "J",
      "author" : [ "J. Schneider", "D. Pochan", "B. Ozbas", "R. Karthikan", "L. Pakstis" ],
      "venue" : "krestsinger, J. Am. Chem. Soc. 124 ",
      "citeRegEx" : "49",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "Release",
      "author" : [ "Y. Nagai", "L.D. Unsworth", "S. Koutsopoulos", "S. Zhang", "J. Control" ],
      "venue" : "115 ",
      "citeRegEx" : "50",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "S",
      "author" : [ "J. Kisiday", "M. Jin", "B. Kurz", "H. Hung", "C. Semino" ],
      "venue" : "Zhang, et al., Proc. Natl. Acad. Sci. U.S.A. 99 (15) ",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "R",
      "author" : [ "B. Law" ],
      "venue" : "Weissleder, C.H. Tung, Biomacromolecules 7 (4) ",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Proc",
      "author" : [ "S. Koutsopoulosa", "L. Unswortha", "Y. Nagaia", "S. Zhang" ],
      "venue" : "Natl. Acad. Sci. U.S.A. 106 (12) ",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "M",
      "author" : [ "F.-C. Alicia", "F.J. Arias" ],
      "venue" : "Alonso, J.C. Rodríguez-Cabello, Biomacromolecular 5 ",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "C",
      "author" : [ "R. Machado", "A.D. Costa", "V. Sencadas" ],
      "venue" : "Garcia-Arévalo, C.M. Costa, J.P. Gomes, et al., Biomed. Mater. 14 ",
      "citeRegEx" : "55",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Acta Biomater",
      "author" : [ "I.G.D. Torre", "M. Santos", "L. Quintanilla", "A. Testera", "M. Alonso", "J.C.R. Cabello" ],
      "venue" : "10 (6) ",
      "citeRegEx" : "56",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Biomater",
      "author" : [ "Y.F. Tian", "G.A. Hudalla", "H. Hana", "J.H. Collier" ],
      "venue" : "Sci. 1 ",
      "citeRegEx" : "58",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Chem",
      "author" : [ "X. Li", "J. Li", "Y. Gao", "Y. Kuang", "J. Shi", "B. Xu", "J. Am" ],
      "venue" : "Soc. 132 (50) ",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Chem",
      "author" : [ "L. Mao", "H. Wang", "M. Tan", "L. Ou", "D. Kongab", "Z. Yang" ],
      "venue" : "Commun. 48 ",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Chem",
      "author" : [ "H. Wang", "L. Lv", "G. Xu", "C. Yang", "J. Sun", "Z. Yang", "J. Mater" ],
      "venue" : "22 ",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Z",
      "author" : [ "H. Wangab" ],
      "venue" : "Yang, Soft Matter 8 ",
      "citeRegEx" : "62",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "B",
      "author" : [ "M.R. Reithofer", "K.-H. Chan", "A. Lakshmanan", "D.H. Lam", "A. Mishra" ],
      "venue" : "Gopalan, et al., Chem. Sci. 5 ",
      "citeRegEx" : "63",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Int",
      "author" : [ "M. Briuglia", "A. Urquhart", "D. Lamprou" ],
      "venue" : "J. Pharm. 474 ",
      "citeRegEx" : "64",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Int",
      "author" : [ "A. Garg", "A.W. Tisdale", "E. Haidari", "E. Kokkoli" ],
      "venue" : "J. Pharm. 366 ",
      "citeRegEx" : "65",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "R",
      "author" : [ "B. Job", "R.H. Zha", "F. Tantakitti", "E. Zhuang" ],
      "venue" : "Zandi, C.J. Newcomba, et al., RSC Adv. 5 ",
      "citeRegEx" : "66",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "C",
      "author" : [ "N. Habibi", "L. Pastorino", "F. Soumetz", "F. Sbrana", "R. Raiteri" ],
      "venue" : "Ruggiero, Colloids Surf., B: Biointerfaces 88 ",
      "citeRegEx" : "67",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Mater",
      "author" : [ "Y. Dori", "H. Bianco-Peled", "S.K. Satija", "G.B. Fields", "M. Tirrell", "J. Biomed" ],
      "venue" : "Res. 50 ",
      "citeRegEx" : "68",
      "shortCiteRegEx" : null,
      "year" : 2000
    }, {
      "title" : "E",
      "author" : [ "A. Mardilovich", "J. Craig", "M. McCammon", "A. Garg" ],
      "venue" : "Kokkoli, Langmuir 22 ",
      "citeRegEx" : "69",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Biophys",
      "author" : [ "M. Magzoub", "A. Graslund", "Q. Rev" ],
      "venue" : "37 (2) ",
      "citeRegEx" : "70",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Adv",
      "author" : [ "B. Gupta", "T. Levchenko", "V. Torchilin" ],
      "venue" : "Drug Delivery Rev. 57 ",
      "citeRegEx" : "71",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Cell",
      "author" : [ "S.M. Fuchs", "R.T. Raines" ],
      "venue" : "Mol. Life Sci. 63 (16) ",
      "citeRegEx" : "72",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Surf",
      "author" : [ "M. Tirrell", "E. Kokkoli", "M. Biesalski" ],
      "venue" : "Sci. 500 (1—3) ",
      "citeRegEx" : "73",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "Y",
      "author" : [ "Y. Liu", "X. He", "Y. Kuang", "S. An", "C. Wang" ],
      "venue" : "Guo, et al., Mol. Pharm. 11 ",
      "citeRegEx" : "74",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "B",
      "author" : [ "X. Xu", "Y. Li", "H. Li", "R. Liu", "M. Sheng" ],
      "venue" : "Bin He, Small 10 (6) ",
      "citeRegEx" : "75",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Eur",
      "author" : [ "L. Pastorino", "N. Habibi", "F. Soumetz", "M. Giulianelli", "C. Ruggiero" ],
      "venue" : "Cell Mater. 22 ",
      "citeRegEx" : "76",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Biochem",
      "author" : [ "N.A. Lockwood", "J.R. Haseman", "M. Tirrell", "K.H. Mayo" ],
      "venue" : "J. 378 ",
      "citeRegEx" : "77",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "E",
      "author" : [ "A. Mardilovich" ],
      "venue" : "Kokkoli, Biomacromolecules 5 ",
      "citeRegEx" : "78",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "E",
      "author" : [ "S.E. Ochsenhirt" ],
      "venue" : "Kokkoli, J.B. McCarthy, M.M. Tirrell, Biomaterials 27 ",
      "citeRegEx" : "79",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "M",
      "author" : [ "T. Pakalns", "K.L. Haverstick", "G.B. Fields", "J.B. McCarthy", "D.L. Mooradian" ],
      "venue" : "Tirrell, Biomaterials 20 ",
      "citeRegEx" : "80",
      "shortCiteRegEx" : null,
      "year" : 1999
    }, {
      "title" : "Mechanics of Contact Interaction",
      "author" : [ "J.K. Loius" ],
      "venue" : "Press syndicate of the university of cambridge, Moscow",
      "citeRegEx" : "81",
      "shortCiteRegEx" : null,
      "year" : 1987
    }, {
      "title" : "M",
      "author" : [ "A.K. Dillow", "S.E. Ochsenhirt", "J.B. McCarthy", "G.B. Fields" ],
      "venue" : "Tirrell, Biomaterials 22 ",
      "citeRegEx" : "82",
      "shortCiteRegEx" : null,
      "year" : 2001
    }, {
      "title" : "Nat",
      "author" : [ "M.A. Yildirim", "K.-I. Goh", "M.E. Cusick", "A.-L. Barab", "M. Vidal" ],
      "venue" : "Biotechnol. 25 (10) ",
      "citeRegEx" : "83",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Nat",
      "author" : [ "S. Zhang" ],
      "venue" : "Biotechnol. 21 ",
      "citeRegEx" : "84",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "J",
      "author" : [ "T. Ritchie", "Y. Grinkova", "T. Bayburt", "I. Denisov" ],
      "venue" : "Zolnerciks, W.M. Atkins, et al., Methods Enzymol. 464 (11) ",
      "citeRegEx" : "85",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "K",
      "author" : [ "S.R. Midtgaard", "M.C. Pedersen", "J.J. Kain Kirkensgaard", "K.K. Sørensen" ],
      "venue" : "Mortensen, K.J. Jensen, et al., Soft Matter 10 ",
      "citeRegEx" : "86",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "L",
      "author" : [ "H. Wang", "Y. Wang", "A. Han", "Y. Cai", "N. Xiao" ],
      "venue" : "Wang, et al., ACS Appl. Mater. Interfaces 6 ",
      "citeRegEx" : "87",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Biochim",
      "author" : [ "L.C. Salay", "K.B. Wei Qi", "L. Tamm", "E. Fernandez Luiz" ],
      "venue" : "Biophys. Acta 1788 ",
      "citeRegEx" : "88",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Acc",
      "author" : [ "J. Shi", "Z. Xiao", "N. Kamaly", "O.C. Farokhzad" ],
      "venue" : "Chem. Res. 44 (10) ",
      "citeRegEx" : "89",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Pept",
      "author" : [ "S.M. Standley", "D.J. Toft", "H. Cheng", "S. Soukasene", "J. Chen", "S.M. Raja", "V. Band", "H. Band", "V.L. Cryns", "S.I. Stupp" ],
      "venue" : "Cancer Res. 70 ",
      "citeRegEx" : "90",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Y",
      "author" : [ "N. Papo" ],
      "venue" : "Shai, Biochemistry 42 ",
      "citeRegEx" : "91",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "G",
      "author" : [ "N.R. Soman", "S.L. Baldwin" ],
      "venue" : "Hu, J.N. Marsh, G.M. Lanza, J.E. Heuser, et al., J. Clin. Invest. 119 ",
      "citeRegEx" : "92",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Curr",
      "author" : [ "D.P. McGregor" ],
      "venue" : "Opin. Pharmacol. 8 ",
      "citeRegEx" : "93",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Chem",
      "author" : [ "M.J. Joralemon", "S. McRae", "T. Emrick" ],
      "venue" : "Commun. 46 ",
      "citeRegEx" : "94",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "A",
      "author" : [ "D.J. Toft", "T.J. Moyer", "S.M. Standley", "Y. Ruff" ],
      "venue" : "Ugolkov, ASC Nano 6 (9) ",
      "citeRegEx" : "95",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "P",
      "author" : [ "S. Fung", "H. Yang" ],
      "venue" : "Chen, Colloids Surf., B: Biointerfaces 55 (2) ",
      "citeRegEx" : "96",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Adv",
      "author" : [ "B.S. Yu Fung", "H. Yang", "P.T. Bhola", "P. Sadatmousavi", "E. Muzar", "M. Liu", "P. Chen" ],
      "venue" : "Funct. Mater. 19 ",
      "citeRegEx" : "97",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Sci",
      "author" : [ "J. Liu", "Y. Xiao", "C. Allen", "J. Pharm" ],
      "venue" : "93 (1) ",
      "citeRegEx" : "98",
      "shortCiteRegEx" : null,
      "year" : 2004
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "hermodynamic and kinetic conditions that are a conseuence of specific and local molecular interactions [1].",
      "startOffset" : 103,
      "endOffset" : 106
    }, {
      "referenceID" : 3,
      "context" : "Self-assembling nanostructures fabicated from natural biomolecular building blocks such s amino acids are highly preferable to their synthetic elf-assembled monolayer (SAMs) alternatives [4] due to heir biocompatibility and ease of ‘‘bottom-up’’ fabricaion [5].",
      "startOffset" : 187,
      "endOffset" : 190
    }, {
      "referenceID" : 4,
      "context" : "Self-assembling nanostructures fabicated from natural biomolecular building blocks such s amino acids are highly preferable to their synthetic elf-assembled monolayer (SAMs) alternatives [4] due to heir biocompatibility and ease of ‘‘bottom-up’’ fabricaion [5].",
      "startOffset" : 257,
      "endOffset" : 260
    }, {
      "referenceID" : 5,
      "context" : "Naturally occurring self-assembly motifs present in proteins such as -helices, -sheets, and coiled-coils can be used to drive the self-assembly process [8].",
      "startOffset" : 152,
      "endOffset" : 155
    }, {
      "referenceID" : 6,
      "context" : "Peptides are the most attractive biomaterials for regenerative scaffolds, since the main ‘‘signaling language’’ in the extracellular matrix (ECM) is mediated via peptide epitopes [9].",
      "startOffset" : 179,
      "endOffset" : 182
    }, {
      "referenceID" : 7,
      "context" : "Self-assembly is important in cell-penetrating peptide (CPP) mechanisms, which play a major role in introducing drugs inside cell membranes and translocating genes inside a nucleus [10].",
      "startOffset" : 181,
      "endOffset" : 185
    }, {
      "referenceID" : 11,
      "context" : "Multiple weak interacions between the fibers prompted the formation of the ydrogel, which was shown to support PC12 cell adhesion nd proliferation into neurons [14].",
      "startOffset" : 160,
      "endOffset" : 164
    }, {
      "referenceID" : 13,
      "context" : "[16] roposed a -hairpin structure design with the sequence KVKVKVKVDPPTKVKVKV, where DP is an enantiomer of roline.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 4,
      "context" : "The interactions between the sidechain aromatic rings create well-ordered tubular structures of significant length (100 m) [5,24].",
      "startOffset" : 123,
      "endOffset" : 129
    }, {
      "referenceID" : 21,
      "context" : "The interactions between the sidechain aromatic rings create well-ordered tubular structures of significant length (100 m) [5,24].",
      "startOffset" : 123,
      "endOffset" : 129
    }, {
      "referenceID" : 14,
      "context" : "exhibited inherent antibacterial activity against both Grampositive and -negative bacteria, likely due to the material disruption of the bacterial cell membrane [17].",
      "startOffset" : 161,
      "endOffset" : 165
    }, {
      "referenceID" : 15,
      "context" : "Analogously, most cationic peptides that form -helices or -sheet-like structures could be inserted into and thus disintegrate negatively charged bacterial cell membranes [18].",
      "startOffset" : 170,
      "endOffset" : 174
    }, {
      "referenceID" : 16,
      "context" : "Earlier studies of collagen mimetic peptides (CMPs) based on the sequence -(Pro-Hyp-Gly)x- or -(Pro-Pro-Gly)x(where Hyp = hydroxyproline) have used models exploring the structure and stability of collagen triple helices [19].",
      "startOffset" : 220,
      "endOffset" : 224
    }, {
      "referenceID" : 17,
      "context" : "To construct 3D scaffolds, CMPs have been incorporated in hydrogels such as photo-polymerizable poly (ethylene oxide) diacrylate PEODA or PA molecules [20].",
      "startOffset" : 151,
      "endOffset" : 155
    }, {
      "referenceID" : 19,
      "context" : "It was identified from Alzheimer’s -amyloid polypeptide studies, where it was proposed as he core recognition motif able to guide self-assembly [22].",
      "startOffset" : 144,
      "endOffset" : 148
    }, {
      "referenceID" : 20,
      "context" : "reported that di-phenylalanine produces anotubes [23], many studies have been carried out to form variety of functional nanostructures from FF-based buildng blocks such as nanotubes, spherical vesicles, nanofibrils, anowires, and ordered molecular chains (Fig.",
      "startOffset" : 49,
      "endOffset" : 53
    }, {
      "referenceID" : 4,
      "context" : "otential applications [5] Printed with permission from RCS.",
      "startOffset" : 22,
      "endOffset" : 25
    }, {
      "referenceID" : 21,
      "context" : "olar species [24] Printed with permission from ACS.",
      "startOffset" : 13,
      "endOffset" : 17
    }, {
      "referenceID" : 4,
      "context" : "as described, in more detail, the various nanostructures erived from FF, their self-assembly mechanisms, and their otential applications [5].",
      "startOffset" : 137,
      "endOffset" : 140
    }, {
      "referenceID" : 21,
      "context" : "This platform was intended s a model system conjugating a hydrophilic drug to selfssembled peptide arrays [24].",
      "startOffset" : 106,
      "endOffset" : 110
    }, {
      "referenceID" : 21,
      "context" : "herefore, both hydrophilic and hydrophobic compounds ould be hosted in these FF nanotubes, giving them an dvantage over other platforms [24].",
      "startOffset" : 136,
      "endOffset" : 140
    }, {
      "referenceID" : 21,
      "context" : "However, FF peptides re still better overall carriers for hydrophobic components ue to their large number of hydrophobic aromatic funcional groups [24].",
      "startOffset" : 147,
      "endOffset" : 151
    }, {
      "referenceID" : 23,
      "context" : "004 A consists of a hydrophobic tail, a linker, a spacer, and hydrophilic head [26].",
      "startOffset" : 79,
      "endOffset" : 83
    }, {
      "referenceID" : 4,
      "context" : "[5,25,108] Printed with permission from RCS and Wiley-VCH.",
      "startOffset" : 0,
      "endOffset" : 10
    }, {
      "referenceID" : 22,
      "context" : "[5,25,108] Printed with permission from RCS and Wiley-VCH.",
      "startOffset" : 0,
      "endOffset" : 10
    }, {
      "referenceID" : 21,
      "context" : "aggregates on nanotube surfaces [24] Printed with permission from ACS.",
      "startOffset" : 32,
      "endOffset" : 36
    }, {
      "referenceID" : 5,
      "context" : "and fiber crosslinking (region III) and a peptide signaling epitope for biological response (region IV) [8,131] Printed with permission",
      "startOffset" : 104,
      "endOffset" : 111
    }, {
      "referenceID" : 5,
      "context" : "As a result f this self-assembly process, various types of structures uch as nanofibers [8], micelles and vesicles [27], nanotapes 28], nanotubes, and ribbons are constructed to reduce the nfavorable interactions of their hydrophobic components ith their surroundings.",
      "startOffset" : 88,
      "endOffset" : 91
    }, {
      "referenceID" : 24,
      "context" : "As a result f this self-assembly process, various types of structures uch as nanofibers [8], micelles and vesicles [27], nanotapes 28], nanotubes, and ribbons are constructed to reduce the nfavorable interactions of their hydrophobic components ith their surroundings.",
      "startOffset" : 115,
      "endOffset" : 119
    }, {
      "referenceID" : 27,
      "context" : "Stupp’s group played significant role in pioneering various PA molecules based n their understanding of the self-assembly mechanism of anofibers for tissue-regeneration applications [30].",
      "startOffset" : 182,
      "endOffset" : 186
    }, {
      "referenceID" : 18,
      "context" : "developed PAs that allowed mineralization ith hydroxyapatite, which mimics the bone ECM to crete bone-interfacing biomaterials [21].",
      "startOffset" : 127,
      "endOffset" : 131
    }, {
      "referenceID" : 18,
      "context" : "This alignment was shown to be similar to i i a f nteractions between hydroxyapatite crystals and collagen brils in natural bone, demonstrating the potential of PA olecules for mimicking the architecture of ECM fibers [21].",
      "startOffset" : 218,
      "endOffset" : 222
    }, {
      "referenceID" : 28,
      "context" : "discovered another remarkable appliation of PA, which allows cell encapsulation for applications uch as blood-vessel engineering [31].",
      "startOffset" : 129,
      "endOffset" : 133
    }, {
      "referenceID" : 29,
      "context" : ", family of cell-penetrating peptides or CPPs) with fatty cid moieties for internalization in HeLa cells [32].",
      "startOffset" : 105,
      "endOffset" : 109
    }, {
      "referenceID" : 29,
      "context" : "This highlights the imporance of the structural design of PAs for their targeted drug elivery [32].",
      "startOffset" : 94,
      "endOffset" : 98
    }, {
      "referenceID" : 28,
      "context" : "cells cultured in string PA; (c) solution colored with trypan blue injected into phosphate buffered saline after heat treatment [31]",
      "startOffset" : 128,
      "endOffset" : 132
    }, {
      "referenceID" : 31,
      "context" : "designed four PAs with hydrazone groups linked to ketone-containing model drugs such as prodan, via hydrazine linkages [34].",
      "startOffset" : 119,
      "endOffset" : 123
    }, {
      "referenceID" : 10,
      "context" : "Interestingly, the quadruple helical structure was transformed to a typical cylindrical nanofiber upon irradiation at 350 nm, indicating its potential use as a responsive system for a broad range of targeted delivery medicine [13].",
      "startOffset" : 226,
      "endOffset" : 230
    }, {
      "referenceID" : 32,
      "context" : ", Lys and Arg) [35] Once exposed to aqueous solutions, the hydrophobic part shields",
      "startOffset" : 15,
      "endOffset" : 19
    }, {
      "referenceID" : 33,
      "context" : "in 1993 with the sequence (AEAEAKAK)2 derived from the yeast protein zuotin [36].",
      "startOffset" : 76,
      "endOffset" : 80
    }, {
      "referenceID" : 34,
      "context" : "These are referred to as olecular hydrogelators since they can interact with each ther to produce gels [37].",
      "startOffset" : 103,
      "endOffset" : 107
    }, {
      "referenceID" : 28,
      "context" : "Recently, several groups have tarted to develop ‘‘self-delivery’’ systems based on hydroelator principles, where the goal is to use therapeutic gents [31,38] to form gels with superior pharmacokinetic rofiles.",
      "startOffset" : 150,
      "endOffset" : 157
    }, {
      "referenceID" : 35,
      "context" : "Recently, several groups have tarted to develop ‘‘self-delivery’’ systems based on hydroelator principles, where the goal is to use therapeutic gents [31,38] to form gels with superior pharmacokinetic rofiles.",
      "startOffset" : 150,
      "endOffset" : 157
    }, {
      "referenceID" : 36,
      "context" : "Currently, one of these hydrogelator systems was ven approved for clinical use by the FDA [39].",
      "startOffset" : 90,
      "endOffset" : 94
    }, {
      "referenceID" : 34,
      "context" : "In addition to commercial drug formulations, several herapeutic agents that include drug candidates such as anreotide, Ganirelix, Biotin, and F-moc L-lysin have been sed to form hydrogelators [37].",
      "startOffset" : 192,
      "endOffset" : 196
    }, {
      "referenceID" : 37,
      "context" : "They ccomplished this through enzyme-regulated self-assembly f small molecules inside cells [40].",
      "startOffset" : 92,
      "endOffset" : 96
    }, {
      "referenceID" : 38,
      "context" : "Ultimately, when combined with cells uch as dermal fibroblasts, these hydrogels can form dense brous networks through the robust secretion of ECM from ells even within these simple Fmoc-FF/RGD scaffolds [41].",
      "startOffset" : 203,
      "endOffset" : 207
    }, {
      "referenceID" : 39,
      "context" : "Bruce Merrifield was one of the pioneers of utilizing nsoluble resins as support during the synthesis of pepides that could then be cleaved off at the end of the rocess to isolate the final peptide in solution [42,43].",
      "startOffset" : 210,
      "endOffset" : 217
    }, {
      "referenceID" : 40,
      "context" : "Bruce Merrifield was one of the pioneers of utilizing nsoluble resins as support during the synthesis of pepides that could then be cleaved off at the end of the rocess to isolate the final peptide in solution [42,43].",
      "startOffset" : 210,
      "endOffset" : 217
    }, {
      "referenceID" : 41,
      "context" : "In ddition, the use of enzymatic procedures (reversed proeolysis) to synthesize specific sequences is gaining renewed nterest [44].",
      "startOffset" : 126,
      "endOffset" : 130
    }, {
      "referenceID" : 42,
      "context" : "ioactive peptide molecules capable of self-assembly into rdered supramolecular structures are ideal building blocks o form hydrogels, scaffolds, and nanofiber gels for use in tisue engineering, regenerative medicine [45], and injectable rug formulations [46,47].",
      "startOffset" : 216,
      "endOffset" : 220
    }, {
      "referenceID" : 43,
      "context" : "ioactive peptide molecules capable of self-assembly into rdered supramolecular structures are ideal building blocks o form hydrogels, scaffolds, and nanofiber gels for use in tisue engineering, regenerative medicine [45], and injectable rug formulations [46,47].",
      "startOffset" : 254,
      "endOffset" : 261
    }, {
      "referenceID" : 44,
      "context" : "ioactive peptide molecules capable of self-assembly into rdered supramolecular structures are ideal building blocks o form hydrogels, scaffolds, and nanofiber gels for use in tisue engineering, regenerative medicine [45], and injectable rug formulations [46,47].",
      "startOffset" : 254,
      "endOffset" : 261
    }, {
      "referenceID" : 45,
      "context" : "Peptide-based hydrogels can be fully biocompatible nd capable of incorporating functional molecules into heir scaffolds [48].",
      "startOffset" : 120,
      "endOffset" : 124
    }, {
      "referenceID" : 44,
      "context" : "Thoughtful design of individual olecules used in preparation of biological scaffolds via selfssembly makes it possible to determine the properties of he larger material [47].",
      "startOffset" : 169,
      "endOffset" : 173
    }, {
      "referenceID" : 47,
      "context" : "In this egard, increased therapeutic efficacy could be achieved by esigning peptides that are stimuli responsive and capable f controlled release [50].",
      "startOffset" : 146,
      "endOffset" : 150
    }, {
      "referenceID" : 47,
      "context" : "They are potentially good choices for preparng a strong drug delivery system able to respond to external timuli under variable physiological conditions of temperture and pH [50].",
      "startOffset" : 173,
      "endOffset" : 177
    }, {
      "referenceID" : 48,
      "context" : "timuli-responsive hydrogels with physically ncapsulated drugs he KLD12 peptide (Ac-KLDLKLDLKLDL) is known for its alterating hydrophobic and ionic hydrophilic amino acids, which an form established -sheet hydrogel structures in aqueous olutions [51].",
      "startOffset" : 245,
      "endOffset" : 249
    }, {
      "referenceID" : 49,
      "context" : "designed a peptideased hydrogel KLD12 that is sensitive to protease and ontained a protease-cleavable region in the self-assembling otif [52].",
      "startOffset" : 137,
      "endOffset" : 141
    }, {
      "referenceID" : 44,
      "context" : "examined the design of a peptide ydrogel formed from self-assembling KLD motifs with two eparate -sheets linked with three or four glycine spacers o prolong the release of doxorubicin (DOX) and Smac (secnd mitochondria-derived activator of caspases)-derived ro-apoptotic peptide (SDPP) [47].",
      "startOffset" : 286,
      "endOffset" : 290
    }, {
      "referenceID" : 47,
      "context" : "assembly of the peptide by means of electrostatic interactions into (b) and (c) fibers and (d) macroscopic hydrogels in buffer [50]",
      "startOffset" : 127,
      "endOffset" : 131
    }, {
      "referenceID" : 47,
      "context" : "The results indicated that release profiles can be tailored by controlling nanofiberdiffusing molecular-level interactions [50].",
      "startOffset" : 123,
      "endOffset" : 127
    }, {
      "referenceID" : 50,
      "context" : "A variety of proteins, such as lysozymes, trypsin inhibitors, BSA, and IgG were also encapsulated within the Ac-(RADA)4-CONH2 peptide hydrogel and released slowly [53].",
      "startOffset" : 163,
      "endOffset" : 167
    }, {
      "referenceID" : 51,
      "context" : "The idea was to create a system as the basis for developing injectable fibrillar biomaterial platforms toward a fully functional, biomimetic, artificial ECM, and cell niches [54].",
      "startOffset" : 174,
      "endOffset" : 178
    }, {
      "referenceID" : 52,
      "context" : ", Nano Today since they were shown to maintain the functional features of (RPE) cells [55].",
      "startOffset" : 86,
      "endOffset" : 90
    }, {
      "referenceID" : 53,
      "context" : "[56] presented compartmentalized capsules responsive to magnetic n o p p eld and temperature.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 46,
      "context" : "Thus, varying the intramolecular folding of small ndividual peptides on the nanoscale can alter macroscopic roperties [49].",
      "startOffset" : 118,
      "endOffset" : 122
    }, {
      "referenceID" : 54,
      "context" : "designed selfssembling depsipeptides that contain ester bonds within he peptide backbone; these degraded in a period of days o weeks by ester hydrolysis [58].",
      "startOffset" : 153,
      "endOffset" : 157
    }, {
      "referenceID" : 65,
      "context" : "Functionalizing stealth PEG-liposomes decorated with PR b peptide-amphiphile [69] were found to function better than ARTICLE ANTOD-496; No.",
      "startOffset" : 77,
      "endOffset" : 81
    }, {
      "referenceID" : 55,
      "context" : "A precursor has lso been designed for developing a Taxol hydrogel without ompromising the activity of Taxol [59].",
      "startOffset" : 108,
      "endOffset" : 112
    }, {
      "referenceID" : 56,
      "context" : "This structures could be applied in the avity after surgical tumor removal for the long-term release f anti-cancer drugs [60].",
      "startOffset" : 121,
      "endOffset" : 125
    }, {
      "referenceID" : 58,
      "context" : "This injectable self-delivery sysem contains a high weight percentage of anti-cancer drugs nd can prolong their release [62].",
      "startOffset" : 120,
      "endOffset" : 124
    }, {
      "referenceID" : 57,
      "context" : "found hat even the conjugates of Taxol with amino acids conaining hydrophilic side chains such as serine, arginine, and lutamic acid were also efficient candidates for formation f molecular hydrogelators [61].",
      "startOffset" : 204,
      "endOffset" : 208
    }, {
      "referenceID" : 6,
      "context" : "ne of the most desirable properties of a drug carrier is to ind specifically with the target site [9], whether cell memranes [64] or molecules of interest.",
      "startOffset" : 98,
      "endOffset" : 101
    }, {
      "referenceID" : 60,
      "context" : "ne of the most desirable properties of a drug carrier is to ind specifically with the target site [9], whether cell memranes [64] or molecules of interest.",
      "startOffset" : 125,
      "endOffset" : 129
    }, {
      "referenceID" : 61,
      "context" : "elf-assembled peptides have also been used to functionalze conventional drug delivery carriers, such as liposomes, or enhanced cellular uptake and targeting [65].",
      "startOffset" : 157,
      "endOffset" : 161
    }, {
      "referenceID" : 62,
      "context" : "In addiion, folate-targeting functions have been investigated for nticancer drug delivery [66].",
      "startOffset" : 90,
      "endOffset" : 94
    }, {
      "referenceID" : 63,
      "context" : "Functional groups of selfssembled structures act as a template for the alignment of ecognition molecules [67].",
      "startOffset" : 105,
      "endOffset" : 109
    }, {
      "referenceID" : 61,
      "context" : "designed a novel peptide-amphiphile equence namely PR b that closely mimics the cell adhesion omain of fibronectin [65].",
      "startOffset" : 115,
      "endOffset" : 119
    }, {
      "referenceID" : 6,
      "context" : "The KSS spacer was used o keep the bioactive region further away from the interace so the availability of the peptide could enhance the inding affinities to the targets [9,68].",
      "startOffset" : 169,
      "endOffset" : 175
    }, {
      "referenceID" : 64,
      "context" : "The KSS spacer was used o keep the bioactive region further away from the interace so the availability of the peptide could enhance the inding affinities to the targets [9,68].",
      "startOffset" : 169,
      "endOffset" : 175
    }, {
      "referenceID" : 61,
      "context" : "(CH2)2 tail spacer, and the peptide headgroup [65] Printed ith permission from ELSEVIER and PUBMED.",
      "startOffset" : 46,
      "endOffset" : 50
    }, {
      "referenceID" : 6,
      "context" : "The ability to design a peptide by sequence-specific modifications at the molecular level allows control of the activities of common motifs for desired applications [9].",
      "startOffset" : 165,
      "endOffset" : 168
    }, {
      "referenceID" : 66,
      "context" : "Membrane penetration function to improve uptake Cell-penetrating amphiphilic peptides such as HIV-Tat based peptides, oligoarginines, and chimeric cell-penetrating peptides have also been applied alone or in combination with other self-assembled peptides for the delivery of therapeutic cargos to their targets [70].",
      "startOffset" : 311,
      "endOffset" : 315
    }, {
      "referenceID" : 67,
      "context" : "CPPs have been used as drug delivery vehicles, because they are able to translocate the cell membrane [71].",
      "startOffset" : 102,
      "endOffset" : 106
    }, {
      "referenceID" : 68,
      "context" : "CPPs, which are cationic short peptides of fewer than 30 amino acids, and oligoarginine-based CPPs with the length of 8—10 arginine residues have shown the most efficient membrane penetration [72].",
      "startOffset" : 192,
      "endOffset" : 196
    }, {
      "referenceID" : 68,
      "context" : "From the classic mechanism [72] the membrane penetration of CPPs is not associated with their self-assembly.",
      "startOffset" : 27,
      "endOffset" : 31
    }, {
      "referenceID" : 7,
      "context" : ", Nano Today internalization mechanism has been demonstrated which shows the role of self-assembly in ability of CPP peptides in traversing cell membranes [10].",
      "startOffset" : 155,
      "endOffset" : 159
    }, {
      "referenceID" : 7,
      "context" : "(3c) Endosomal release [10] Printed with",
      "startOffset" : 23,
      "endOffset" : 27
    }, {
      "referenceID" : 69,
      "context" : "After incorporation of IV-H1 peptidemphiphile, they maintained their native triple-helical tructure and enhanced uptake of the IV-H1 modified lipoomes over non-targeted liposomes [73].",
      "startOffset" : 179,
      "endOffset" : 183
    }, {
      "referenceID" : 30,
      "context" : "Arginine PA integrated n liposomes enhanced the uptake of model reagents by CF7 breast cancer cells compared to native liposomes and ree reagents [33].",
      "startOffset" : 146,
      "endOffset" : 150
    }, {
      "referenceID" : 30,
      "context" : "paclitaxel) antiancer agents have been loaded in arginine-rich peptide iposomes in order to improve the uptake of both drugs nside cancer cells [33].",
      "startOffset" : 144,
      "endOffset" : 148
    }, {
      "referenceID" : 71,
      "context" : "Confocal scanning microscope esults indicated NVs can considerably enhance the endoytosis of DOX into HepG2 cells and deliver DOX to their uclei [75].",
      "startOffset" : 145,
      "endOffset" : 149
    }, {
      "referenceID" : 6,
      "context" : "A biomimetic embrane allows one to study cell membrane signals nd interactions with ligands directly [9].",
      "startOffset" : 101,
      "endOffset" : 104
    }, {
      "referenceID" : 72,
      "context" : "Examples are polyethylene glycol hydrogels, iodegradable copolymers, and SAMs [76].",
      "startOffset" : 78,
      "endOffset" : 82
    }, {
      "referenceID" : 6,
      "context" : "urthermore, these long chains can also improve the stabilty and activity of the peptide relative to the parent protein y protecting the secondary structure [9,77].",
      "startOffset" : 156,
      "endOffset" : 162
    }, {
      "referenceID" : 73,
      "context" : "urthermore, these long chains can also improve the stabilty and activity of the peptide relative to the parent protein y protecting the secondary structure [9,77].",
      "startOffset" : 156,
      "endOffset" : 162
    }, {
      "referenceID" : 64,
      "context" : "Further studies have used model LB membranes comosed of peptide-amphiphiles and lipidated polyethylene lycol [68] to investigate the fundamental effects of pH, lectrostatic interactions, hydrogen bonding on bioadheion, ligand availability, cell spreading, and migration vailability.",
      "startOffset" : 109,
      "endOffset" : 113
    }, {
      "referenceID" : 75,
      "context" : "Studies on LB membranes f triple-helical collagen mimetic peptides showed that varous head groups of PEG lipidated molecules with different ength could affect ligand accessibility and eventually conrol adhesion and spreading of melanoma cells [79].",
      "startOffset" : 243,
      "endOffset" : 247
    }, {
      "referenceID" : 82,
      "context" : ", Nano Today B membranes, and the effect of their secondary strucure on cell adhesion, cell spreading, and integrin binding ffinity was investigated by Johnson, Kendall, Roberts (JKR) a p s he 18A peptide trimer in solution [86] Printed with permission",
      "startOffset" : 224,
      "endOffset" : 228
    }, {
      "referenceID" : 79,
      "context" : "Almost 30% of the human genome codes for memrane proteins, which are principal targets for nearly 50% f medical drugs [83].",
      "startOffset" : 118,
      "endOffset" : 122
    }, {
      "referenceID" : 80,
      "context" : "However, understanding their funcionality remains a challenge, and only a limited number of igh-resolution structural studies have been carried out so ar [84].",
      "startOffset" : 154,
      "endOffset" : 158
    }, {
      "referenceID" : 80,
      "context" : "New biomimetic materials uch as self-assembling proteins allow membrane proteins o organize in a 3D membrane lattice, opening new posibilities for their crystallization, biochemical studies, and ntegration in nanodevices [84].",
      "startOffset" : 221,
      "endOffset" : 225
    }, {
      "referenceID" : 81,
      "context" : "In combiation with phospholipids, they can self-assemble to form iscoidal-shaped particles that can stabilize membrane proeins [85].",
      "startOffset" : 127,
      "endOffset" : 131
    }, {
      "referenceID" : 82,
      "context" : "examined n ApoA1 mimetic peptide referred to as A18, and its soluion structure [86].",
      "startOffset" : 79,
      "endOffset" : 83
    }, {
      "referenceID" : 82,
      "context" : "[86] was to investigate whether A18 could provide the flexibility of bicelles along with the native membrane-like environment of nanodiscs.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 83,
      "context" : "Interestingly, the results demonstrated that the utilization of D-amino acids in self-assembling peptides boosts their cellular membrane localization [87].",
      "startOffset" : 150,
      "endOffset" : 154
    }, {
      "referenceID" : 83,
      "context" : "[87] demonstrated the possibility of using such D-amino acid-based peptides to engineer cell surfaces.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 84,
      "context" : "in order to mimic the toxicity and structural behavior of -amyloid peptide (A ) [88].",
      "startOffset" : 80,
      "endOffset" : 84
    }, {
      "referenceID" : 85,
      "context" : "Nanosized carriers offer advantages such as high drug-loading ability, improved stability by avoiding fast clearance by the reticuloendothelial and renal systems, and minimized drug loss during blood circulation [89].",
      "startOffset" : 212,
      "endOffset" : 216
    }, {
      "referenceID" : 44,
      "context" : "For example, injectable ydrogel formulations can be placed in direct contact with umor tissues and therefore improve the safety and effiacy of cancer treatment [47].",
      "startOffset" : 160,
      "endOffset" : 164
    }, {
      "referenceID" : 21,
      "context" : "Nanotubes also have been pplied to load doxorubicin with high efficiency in their nner core [24].",
      "startOffset" : 92,
      "endOffset" : 96
    }, {
      "referenceID" : 30,
      "context" : "Moreover, modifications have been applied to increase argeting activity and intracellular delivery efficacy [33].",
      "startOffset" : 108,
      "endOffset" : 112
    }, {
      "referenceID" : 86,
      "context" : "designed a PA with highly cationic memrane lytic (Lysin) sequence (KLAKLAK)2 conjugated to lauryl cid (C16-A4G3(KLAKLAK)2) capable of forming cylindrical anofibers and disrupting cell membranes [90].",
      "startOffset" : 194,
      "endOffset" : 198
    }, {
      "referenceID" : 87,
      "context" : "The results emonstrated that PA is more cytotoxic against the transormed cell membranes of cancer cells due to increased egative charge on these surfaces [91].",
      "startOffset" : 154,
      "endOffset" : 158
    }, {
      "referenceID" : 88,
      "context" : "Moreover it was evealed that in addition to passive permeation, KALA epiope mediated uptake targeting [92].",
      "startOffset" : 102,
      "endOffset" : 106
    }, {
      "referenceID" : 89,
      "context" : "A limitation associated ith these kinds of PAs, however, is rapid degradation of pepide after systematic delivery [93].",
      "startOffset" : 114,
      "endOffset" : 118
    }, {
      "referenceID" : 90,
      "context" : "One tactic to enhance he therapeutic-delivery vehicle is to functionalize the surace with polymers such as PEG, which can protect from roteolysis, improve circulation time, and lessen immune esponse [94].",
      "startOffset" : 199,
      "endOffset" : 203
    }, {
      "referenceID" : 91,
      "context" : "introduced he use of cytotoxic KLAK PA and a co-assembled combinaion of pegylated PA (PEG PA) to make an effective antitumor herapy [95].",
      "startOffset" : 132,
      "endOffset" : 136
    }, {
      "referenceID" : 92,
      "context" : "EAK was able to increase the stability of PT in aqueous solution [96,97] at a concentration much igher than the drug’s solubility in water (∼0.",
      "startOffset" : 65,
      "endOffset" : 72
    }, {
      "referenceID" : 93,
      "context" : "EAK was able to increase the stability of PT in aqueous solution [96,97] at a concentration much igher than the drug’s solubility in water (∼0.",
      "startOffset" : 65,
      "endOffset" : 72
    }, {
      "referenceID" : 44,
      "context" : "verified he possible use of in situ-forming hydrogels made of selfssembled KLD motifs to tune or extend the release of the onventional cytotoxic drug (doxorubicin) [47].",
      "startOffset" : 164,
      "endOffset" : 168
    }, {
      "referenceID" : 70,
      "context" : "004 rom endosomal vesicles, and prompt gene expression both n vitro and in vivo [74,110].",
      "startOffset" : 80,
      "endOffset" : 88
    } ],
    "year" : 2016,
    "abstractText" : null,
    "creator" : "Elsevier"
  }
}